PoSter SeSSionS - SIOP 2012, 44th Congress of the International ...
02.06.2013 • Views
Share Embed Flag

PoSter SeSSionS - SIOP 2012, 44th Congress of the International ...

PoSter SeSSionS - SIOP 2012, 44th Congress of the International ...

PoSter SeSSionS - SIOP 2012, 44th Congress of the International ...

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
siop2012.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

<strong>PoSter</strong> <strong>SeSSionS</strong><br />

83

Poster sessions<br />

Poster Sessions<br />

Friday, October 5, <strong>2012</strong> - Monday, October 8, <strong>2012</strong><br />

All posters will be discussed during a poster discussion session to be held on Sunday, October 7, <strong>2012</strong> 16.30-18.00<br />

08:00-18:00 EXHIBIT HALL<br />

Poster Topic: Acute Lymphoblastic Leukaemia - Session 1<br />

Moderator: Barbara De Moerloose<br />

PA001 - PA025<br />

GENE EXPRESSION-BASED IN SILICO SCREENING FOR GLUCOCORTICOID-SENSITIZING THERAPEUTICS IN<br />

MLL-REARRANGED ALL IDENTIFIES PI3K INHIBITORS AS POTENTIAL MODULATORS OF PREDNISOLONE<br />

RESISTANCE<br />

Jill Spijkers-Hagelstein<br />

SRC KINASE-INDUCED PHOSPHORYLATION OF ANNEXIN A2 MEDIATES GLUCOCORTICOID RESISTANCE IN<br />

MLL-REARRANGED INFANT ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Jill Spijkers-Hagelstein<br />

PROGNOSTIC SIGNIFICANCE OF MLL FUSION GENE TRANSCRIPTS (FGT) MONITORING AS MARKER OF<br />

MINIMAL RESIDUAL DISEASE (MRD) IN INFANT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)<br />

Grigory Tsaur<br />

EXCELLENT OUTCOME IN MLL-NEGATIVE INFANTS WITH ALL TREATED BY ATRA CONTAINING MLL-BABY<br />

PROTOCOL<br />

Larisa Fechina<br />

MOTOR PERFORMANCE AND FUNCTIONAL EXERCISE CAPACITY IN SURVIVORS OF PEDIATRIC ACUTE<br />

LYMPHOBLASTIC LEUKEMIA<br />

Annelies Hartman<br />

COMPARISON OF MULTICOLOUR FLOW CYTOMETRY AND PCR OF FUSION GENE TRANSCRIPTS<br />

APPLICABILITY FOR MINIMAL RESIDUAL DISEASE DETECTION IN CHILDHOOD ACUTE LYMPHOBLASTIC<br />

LEUKEMIA<br />

Alexander Popov<br />

MINIMAL RESIDUAL DISEASE AT DAY 14 AND 28 OF REMISSION INDUCTION AS A PROGNOSTIC FACTOR<br />

OF SURVIVAL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED AT HOSPITAL CIVIL DE<br />

GUADALAJARA DR. JUAN I. MENCHACA<br />

Sergio Gallegos-Castorena<br />

MOLECULAR ANALYSIS OF FUSION GENES AMONG PAEDIATRIC B-LINEAGE ACUTE LYMPHOBLASTIC<br />

LEUKAEMIA IN KERALA, SOUTH INDIA AND THEIR EFFECT ON EARLY TREATMENT OUTCOME<br />

Priyakumari Thankamony<br />

PATTERN OF RELAPSE OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), 25 YEARS OF EXPERIENCE<br />

OF THE ARGENTINE GROUP OF ACUTE LEUKEMIA (GATLA) WITH BFM TYPE PROTOCOLS<br />

Monica Makiya<br />

IMPROVED OUTCOME FOR CHILDREN WITH HIGH RISK (HR) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN<br />

ARGENTINA. A GATLA REPORT<br />

Cecilia Riccheri<br />

EXCELLENT OUTCOME WITH CONTEMPORARY THERAPY FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA<br />

(ALL) IN SAUDI ARABIA<br />

Fahd Al Manjomi<br />

Poster Board No<br />

PA001<br />

PA002<br />

PA003<br />

PA004<br />

PA005<br />

PA006<br />

PA007<br />

PA008<br />

PA009<br />

PA010<br />

PA011

DISTINCT GENETICS OF TEENAGE AND YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA<br />

Frederik van Delft<br />

CENTRAL NERVOUS SYSTEM EVENTS DURING TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC<br />

LEUKEMIA (ALL)<br />

Aruna Rajendran<br />

DECREASING TREATMENT RELATED MORTALITY IN ACUTE LYMPHOBLASTIC LEUKEMIA IN A DEVELOPING<br />

COUNTRY<br />

Amita Trehan<br />

TREATMENT RESULTS AND RELAPSE ANALYSIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN<br />

THE SLOVAK REPUBLIC TREATED ACCORDING TO ALLIC BFM 2002 PROTOCOL<br />

Emilia Kaiserova<br />

ABSOLUTE LYMPHOCYTE COUNT RECOVERY AS PROGNOSTIC MARKER OF SURVIVAL IN PEDIATRIC<br />

PRECURSOR B ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Muhammad Asim<br />

COAGULATION FACTOR XIIIA IS A NEW PROGNOSTIC FACTOR IN CHILDHOOD ACUTE LYMPHOBLASTIC<br />

LEUKEMIA<br />

Csongor Kiss<br />

CONSUMPTION OF FRUITS,VEGETABLES AND MILK PRODUCTS IN CHILDHOOD DECREASES THE RISK OF<br />

PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Anand Prakash<br />

A COMPREHENSIVE STRATEGY REDUCES TREATMENT MORTALITY AND ABANDONMENT RATES IN POOR<br />

CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED AT INSTITUTO NACIONAL DE CANCEROLOGIA,<br />

BOGOTA, COLOMBIA<br />

Martha Ligia Pina Quintero<br />

CENTRAL NERVOUS SYSTEM COMPLICATIONS IN CHILDREN UNDERGOING TREATMENT FOR<br />

HAEMATOLOGICAL MALIGNANCIES: A DEVELOPING WORLD EXPERIENCE<br />

Nivedita Dhingra<br />

SYMPTOM DIAGNOSIS INTERVAL IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: PROGNOSTIC IMPACT<br />

AND ASSOCIATION WITH CLINICO-DEMOGRAPHIC FACTORS<br />

Ketan Kulkarni<br />

PROGNOSTIC SIGNIFICANCE OF ABSOLUTE LYMPHOCYTE COUNT IN PEDIATRIC ACUTE LYMPHOBLASTIC<br />

LEUKEMIA<br />

Iman Sidhom<br />

SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR-A LEVELS DURING THERAPY AND AT RELAPSE IN<br />

PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Veronique Dinand<br />

EXPRESSION OF S100A8 IN LEUKEMIC CELLS PREDICTS POOR SURVIVAL IN 172 PATIENTS WITH ALL WHO<br />

ARE UNDER 15 YEARS OLD<br />

Minghua Yang<br />

SARCOPENIA IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Meera Rayar<br />

PA012<br />

PA013<br />

PA014<br />

PA015<br />

PA016<br />

PA017<br />

PA018<br />

PA019<br />

PA020<br />

PA021<br />

PA022<br />

PA023<br />

PA024<br />

PA025<br />

Poster sessions

Poster sessions<br />

Poster Topic: Acute Lymphoblastic Leukaemia - Session 2<br />

Moderator: Monique den Boer<br />

PA026 - PA052<br />

PREDICTORS OF COMPLICATIONS IN FEBRILE NEUTROPENIA IN CHILDREN WITH ACUTE LYMPHOBLASTIC<br />

LEUKEMIA<br />

Sapna Oberoi<br />

HUMAN HEMATOPOIETIC STEM CELL KINETICS AFTER CHEMOTHERAPY: AN ANALYSIS OF MUTANT<br />

ERYTHROCYTES AFTER TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Veronica Neefjes<br />

CYTOMEGALOVIRUS RETINITIS IN CHILDREN AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA<br />

IN LEBANON<br />

Samar Muwakkit<br />

THE TIMING OF CENTRAL VENOUS CATHETER INSERTION AND RISK OF VENOUS THROMBO-EMBOLISM IN<br />

PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA<br />

Elsje van Rijswijk<br />

VITAMIN D MODULATES OSTEOCYTE RESPONSE TO DEXAMETHASONE IN VITRO: A POTENTIAL<br />

THERAPEUTIC STRATEGY FOR GLUCOCORTICOID-INDUCED OSTEONECROSIS?<br />

Madeleine R. Adams<br />

PROSPECTIVE STUDY ON INCIDENCE, RISK FACTORS, AND LONG-TERM OUTCOME OF OSTEONECROSIS IN<br />

PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Mariel L. te Winkel<br />

PNEUMOCYSTIS CARINII PNEUMONITIS (PCP) PROPHYLAXIS IN PAEDIATRIC PATIENTS WITH ACUTE<br />

LYMPHOBLASTIC LEUKAEMIA<br />

Patricia Marian O’Hare<br />

MANAGEMENT OF HYPERLEUCOCYTOSIS AND PREVENTION OF TUMOUR LYSIS SYNDROME BY<br />

ADMINSTRATION OF L-ASPARGINASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Vishal Sondhi<br />

NO EVIDENCE OF INCREASED ASPARAGINE LEVELS IN THE BONE MARROW NICHE OF PATIENTS WITH<br />

ACUTE LYMPHOBLASTIC LEUKEMIA DURING ASPARAGINASE THERAPY<br />

Wing Tong<br />

DIMINISHED ASPARAGINASE CLEARANCE DUE TO A MUTATION IN CATHEPSIN B<br />

Laurens van der Meer<br />

HIGH EARLY RESPONSE AND LOW INDUCTION DEATH RATES AND BETTER EFS WITH EARLY PEG<br />

ASPARAGINASE IN CHILDHOOD ALL - UPDATE OF A PILOT STUDY MB 2005<br />

Alexandr Karachunskiy<br />

SUB-CLONAL CYTOGENETIC HETEROGENEITY IN HIGH HYPERDIPLOID ACUTE LYMPHOBLASTIC LEUKAEMIA<br />

Donat Alpar<br />

IMPROVEMENT IN RISK GROUPS CLASSIFICATION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA:<br />

CRYPTIC DUPLICATIONS AND DELETIONS<br />

Elixabet López López<br />

FREQUENCIES OF ETV6-RUNX1 GENE FUSION AND SECONDARY CHROMSOMAL ABNORMALITIES IN<br />

PEDIATRIC LYMPHOBLASTIC LEUKEMIA<br />

Sherine Salem<br />

Poster Board No<br />

PA026<br />

PA027<br />

PA028<br />

PA029<br />

PA030<br />

PA031<br />

PA032<br />

PA033<br />

PA034<br />

PA035<br />

PA036<br />

PA037<br />

PA038<br />

PA039

2-DEOXY-D-GLUCOSE INDUCES APOPTOSIS IN BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA AND<br />

SYNERGIZES WITH BCR/ABL TYROSINE KINASE INHIBITORS<br />

Julio C. Barredo<br />

INTERROGATING SIGNALING NETWORKS AND MECHANISMS OF CHEMOTHERAPY RESISTANCE IN T-CELL<br />

ACUTE LYMPHOBLASTIC LEUKEMIA WITH PHOSPHOFLOW CYTOMETRY<br />

Michelle L. Hermiston<br />

PHENOTHIAZINE ANTIPSYCHOTICS ACTIVATE THE PP2A TUMOUR SUPPRESSOR FOR THERAPEUTIC ACTIVITY<br />

IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Alejandro Gutierrez<br />

INVOLVEMENT OF INTRON 3 OF ARID5B IN THE RISK OF DEVELOPING CHILDHOOD ACUTE LYMPHOBLASTIC<br />

LEUKEMIA<br />

Africa Garcia-Orad<br />

MICRORNAS AS POTENCIAL MARKERS OF TOXICITY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Africa Garcia-Orad<br />

NEW MARKERS IN SUSCEPTIBILITY TO DEVELOP CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: MIRNAS<br />

Africa Garcia-Orad<br />

EXPORTIN 7: A NOVEL TARGET TO CHEMOTHERAPY SENSITIVITY IN ACUTE LYMPHOBLASTIC LEUKEMIA CELL<br />

LINES<br />

Vanessa Silva Silveira<br />

KIRS GENE PROFILE IN PEDIATRIC B ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)<br />

Hatzipantelis Emmanouil<br />

REGULATION OF XIAP-IRES ACTIVITY BY EIF4GI, P97 AND EIF4A IN AN IN VITRO TRANSLATION SYSTEM<br />

Nina Weichert<br />

IGF-1R EXPRESSION AND EFFECT OF IGF-1 ON B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA<br />

CELLS<br />

Hiroyuki Yamada<br />

THE ROLE OF PHARMACOGENETICS IN THE TREATMENT OF LEBANESE PATIENTS WITH CHILDHOOD ACUTE<br />

LYMPHOBLASTIC LEUKEMIA<br />

Samar Muwakkit<br />

METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) POLYMORPHISMS IN CHILDREN WITH ACUTE<br />

LYMPHOBLASTIC LEUKEMIA (ALL), AND THE NEED FOR REDUCTION OR CESSATION OF METHOTREXATE<br />

DOSES DURING MAINTENANCE THERAPY: THE POLISH MULTICENTER ANALYSIS<br />

Elwira Szychot<br />

SHMT1 POLYMORPHISM IS ASSOCIATED WITH EARLY CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA<br />

Tállita Meciany Vieira<br />

PA040<br />

PA041<br />

PA042<br />

PA043<br />

PA044<br />

PA045<br />

PA046<br />

PA047<br />

PA048<br />

PA049<br />

PA050<br />

PA051<br />

PA052<br />

Poster sessions<br />

87

Poster sessions<br />

Poster Topic: O<strong>the</strong>r leukaemias and MDS<br />

Moderator: Josef H. Vormoor<br />

PB001 - PB013<br />

IMATINIB MESYLATE IN THE TREATMENT OF PAEDIATRIC CHRONIC MYELOID LEUKEMIA: A STUDY OF 55<br />

PATIENTS FROM A TERTIARY CARE CANCER CENTRE IN PAKISTAN<br />

Aqeela Rashid<br />

JUVENILE MYELOMONOCYTIC LEUKEMIA, A NEGLECTED ENTITY IN THE DEVELOPING WORLD: A SINGLE<br />

CENTRE EXPERIENCE FROM INDIA<br />

Saroj Prasad Panda<br />

COULD WT1 GENE EXPRESSION BE USEFUL MARKER FOR MONITORING OF MINIMAL RESIDUAL DISEASE IN<br />

PEDIATRIC ACUTE MYELOID LEUKEMIA?<br />

Walentyna Balwierz<br />

FLT3, NPM1 AND CEBPA MUTATIONS IN CHILDHOOD ACUTE MYELOID LEUKAEMIA IN ARGENTINA<br />

Patricia Rubio<br />

LONG-TERM OUTCOME OF PEDIATRIC AML1/ETO POSITIVE ACUTE MYELOID LEUKEMIA FOLLOWING<br />

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FIRST COMPLETE REMISSION<br />

Hong Hoe Koo<br />

ANALYSIS OF THE TWO RECIPROCAL FUSION GENES MLL-NEBL AND NEBL-MLL IDENTIFIED IN AN INFANT<br />

MYELOID LEUKEMIA<br />

Mariana Emerenciano<br />

CHARACTERISATION OF MLL REARRANGEMENTS BY LDI-PCR IN ARGENTINA: SET UP OF MRD FOR INFANT<br />

LEUKAEMIA<br />

Adrian Mansini<br />

SYNERGISTIC AND ANTAGONISTIC AML CELL TYPE-SPECIFIC RESPONSES TO 5-AZA-2’-DEOXYCYTIDINE AND<br />

1-H-D-ARABINOFURANOSYLCYTOSINE<br />

Abeer Abd Elmoneim<br />

CLADRIBINE(2-CDA) AND CYTARABINE(ARA-C) IS AN EFFECTIVE SALVAGE REGIMEN IN REFRACTORY/<br />

RELAPSED ACUTE MYELOID LEUKAEMIA IN CHILDREN<br />

Girish Chinnaswamy<br />

A SINGLE CENTRE RETROSPECTIVE STUDY OF CYTOGENETIC PROFILE, MANAGEMENT AND OUTCOME OF<br />

ACUTE MYELOID LEUKAEMIA IN CHILDREN<br />

Patricia Marian O’Hare<br />

FUNGAL INFECTIONS IN CHILDREN UNDERGOING CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA<br />

Marina Servitzoglou<br />

HYPEREOSINOPHILIC SYNDROME IN CHILDREN<br />

M.M. van den Heuvel-Eibrink<br />

DIAGNOSTIC IMAGING AND MANAGEMENT OF MEDIASTINAL MASS-ASSOCIATED AIRWAY AND VASCULAR<br />

COMPRESSION IN PAEDIATRIC T-CELL MALIGNANCY<br />

Christine Lisa Rawlings<br />

Poster Board No<br />

PB001<br />

PB002<br />

PB003<br />

PB004<br />

PB005<br />

PB006<br />

PB007<br />

PB008<br />

PB009<br />

PB010<br />

PB011<br />

PB012<br />

PB013

Poster Topic: Lymphomas + Histiocytosis<br />

Moderator: R. Maarten Egeler<br />

PC001 - PC021<br />

EXCELLENT OUTCOME IN PEDIATRIC HODGKIN DISEASE WITH WITH TREATMENT PRIMARILY BASED ON<br />

CHEMOTHERAPY WITH ABVD/COPDAC<br />

Muhammad Shamvil Ashraf<br />

THE RESULTS OF MODIFIED VERSION OF GPOH-HD-95 IN CHILDREN WITH HODGKIN’S DISEASE: EGE<br />

PEDIATRIC ONCOLOGY GROUP EXPERIENCE<br />

Serra Kamer<br />

A LONG-TERM FOLLOW-UP REPORT ON THE MODIFIED PEDIATRIC PROTOCOL DAL-HD-90 FOR<br />

ADOLESCENTS AND YOUNG ADULTS WITH HODGKIN LYMPHOMA<br />

Sergey V. Semochkin<br />

PHENOTYPIC CHARACTERISATION BY FLOW CYTOMETRY (FC) OF PAEDIATRIC NON-HODGKIN LYMPHOMA<br />

(NHL): EXPERIENCE OF A REFERRAL INSTITUTION IN ARGENTINA<br />

Andrea Raquel Bernasconi<br />

CURRENT OUTCOMES OF HODGKIN’S DISEASE (HD) AMONG CHILDREN IN INDIA: A SYSTEMATIC ANALYSIS<br />

Kanakkande Aabideen<br />

PEDIATRIC MATURE B CELL NON HODGKIN’S LYMPHOMA. THE CHILDREN CANCER HOSPITAL - EGYPT<br />

EXPERIENCE<br />

Hany Abdel Rahman<br />

CIRCULATING EPSTEIN-BARR VIRUS-DNA AS A BIOMARKER OF TREATMENT RESPONSE IN PEDIATRIC<br />

HODGKIN LYMPHOMA<br />

Veronique Dinand<br />

MLL REARRANGEMENT IN NON-INFILTRATED BONE MARROW IN AN INFANT WITH ISOLATED PRECURSOR<br />

B-LYMPHOBLASTIC LYMPHOMA<br />

Martina Ahlmann<br />

EVALUATION OF PET/CT AND CECT FOR STAGING, INTERIM AND POST-TREATMENT RESPONSE ASSESSMENT<br />

IN PEDIATRIC HODGKIN LYMPHOMA: A PROSPECTIVE STUDY<br />

Sameer Bakhshi<br />

EVALUATION OF MRI DWIBS AND FDG PET-CT IN FOLLOW UP OF PEDIATRIC LYMPHOMAS<br />

Monika Csóka<br />

PTLD IN CHILDREN: A SINGLE CENTRE EXPERIENCE<br />

Marleen Renard<br />

DIFFERENCES IN CLINICAL COURSE BETWEEN NON-HODGKIN’S LYMPHOMA (NHL) IN IMMUNOCOMPETENT<br />

AND IMMUNOCOMPROMISED PATIENTS WITH NIJMEGEN BREAKAGE SYNDROME (NBS)<br />

Anna Wakulinska<br />

OSTEONECROSIS IN ADOLESCENTS TREATED FOR HODGKIN’S LYMPHOMA, A TERTIARY UNIT EXPERIENCE<br />

Harsha Prasada Lashkari<br />

GENETIC ABERRATIONS IN PEDIATRIC FOLLICULAR LYMPHOMA<br />

Idoia Martin-Guerrero<br />

DIAGNOSTIC PROSPECTS AND ISOFORM-DEPENDENT FUNCTIONS OF BURKITT LYMPHOMA SPECIFIC<br />

PROTEIN ZNF385B<br />

Kazutoshi Iijima<br />

Poster Board No<br />

PC001<br />

PC002<br />

PC003<br />

PC004<br />

PC005<br />

PC006<br />

PC007<br />

PC008<br />

PC009<br />

PC010<br />

PC011<br />

PC012<br />

PC013<br />

PC014<br />

PC015<br />

Poster sessions

Poster sessions<br />

LANGERHANS CELL HISTIOCYTOSIS (LCH): THE EXPERIENCE OF THE ISTITUTO NAZIONALE DEI TUMORI OF<br />

MILAN, ITALY<br />

Serena Catania<br />

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) IN INFANTS: A SINGLE CENTRE EXPERIENCE<br />

Mohammed Ramzan<br />

CHILDHOOD HISTIOCYTOSIS IN SOUTH AFRICAN PAEDIATRIC ONCOLOGY UNITS<br />

Mariana Kruger<br />

TREATMENT OF RELAPSED/REFRACTORY LANGERHANS CELL HISTIOCYTOSIS: A SINGLE CENTRE<br />

EXPERIENCE FROM DEVELOPING WORLD<br />

Vikas Dua<br />

INFECTIOUS TRIGGERS AT DIAGNOSIS IN 54 SPANISH CHILDREN WITH LYMPHOHISTIOCYTOSIS<br />

HEMOFAGOCYTIC (HLH)<br />

Itziar Astigarraga<br />

PULMONARY INVOLVEMENT IN SPANISH PAEDIATRIC LANGERHANS CELL HISTIOCYTOSIS CASES<br />

Itziar Astigarraga<br />

Poster Topic: Bone tumours<br />

Moderator: Stefan Bielack<br />

PD001 - PD023<br />

SHOULD ADOLESCENTS WITH EWING SARCOMA BE TREATED IN PAEDIATRIC OR NON-PAEDIATRIC<br />

ONCOLOGY INSTITUTIONS? AN ANALYSIS OF GPOH EWING TRIAL (CESS/EICESS/EURO-E.W.I.N.G.) DATA<br />

Michael Paulussen<br />

LONG TERM OUTCOME OF CONVENTIONAL HIGH GRADE OSTEOSARCOMA IN CHINESE CHILDREN AND<br />

ADOLESCENTS<br />

Vincent Lee<br />

SUCCESSFUL TREATMENT FOR OSTEOSARCOMA PATIENTS UNDER 25 YEARS OF AGE<br />

Tomoko Iehara<br />

CLINICAL RESULTS AND PROGNOSTIC FACTORS OF PRIMARY OSTEOSARCOMA OF EXTREMITIES WITH<br />

PULMONARY METASTASIS: CCHE EXPERIENCE<br />

Manal Zamzam<br />

IMPACT OF PULMONARY NODULES IDENTIFIED BY CT SCAN ON TREATMENT AND OUTCOME OF CHILDREN<br />

WITH SOLID TUMOURS<br />

Jennifer Reichek<br />

PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF LIPOSOMAL MIFAMURTIDE (L-MTP-PE) IN<br />

ADULT VOLUNTEERS WITH MILD AND MODERATE RENAL IMPAIRMENT (RI)<br />

Karthik Venkatakrishnan<br />

PHARMACOKINETICS OF METHOTREXATE IN PEDIATRIC OSTEOSARCOMA<br />

Marta Hegyi<br />

PHARMACOKINETIC, PHARMACOGENETIC AND PHARMACODYNAMIC STUDY OF HIGH DOSE METHOTREXATE<br />

IN PEDIATRIC OSTEOSARCOMA PATIENTS AT A SINGLE INSTITUTION IN ARGENTINA<br />

Paula Schaiquevich<br />

PC016<br />

PC017<br />

PC018<br />

PC019<br />

PC020<br />

PC021<br />

Poster Board No<br />

PD001<br />

PD002<br />

PD003<br />

PD004<br />

PD005<br />

PD006<br />

PD007<br />

PD008

EFFICACY AND SAFETY OF GLUCARPIDASE FOR ROUTINE USE AFTER HIGH DOSE METHOTREXATE IN<br />

PATIENTS WITH OSTEOSARCOMA<br />

Martha Perisoglou<br />

LYMPHOPENIA AS A PROGNOSTIC FACTOR FOR HISTOLOGICAL NECROSIS AND TREATMENT COMPLIANCE IN<br />

OSTEOSARCOMA<br />

Santosh Kumar<br />

THE VALUE OF DIFFUSION-WEIGHTED IMAGING IN EWING’S SARCOMA AND OSTEOSARCOMA IN CHILDREN<br />

AND YOUNG ADULTS: A RELIABLE PARAMETER FOR THERAPY ASSESSMENT? PRELIMINARY RESULTS<br />

Steven Pans<br />

ASSESSMENT OF KINETICS OF PERIPHERAL BLOOD T REGULATORY CELLS (TREGS) IN PNET/ EWING<br />

SARCOMA: A PROSPECTIVE STUDY<br />

Tilak Tejomurtula<br />

OSTEOSARCOMA -WHAT CHOICE DOES THE PATIENT HAVE IN A RESOURCE LIMITED SETTING?<br />

Rikki John<br />

RECONSTRUCTION WITH GROWING ENDOPROSTHESIS AFTER RESECTION PRIMARY MALIGNANT BONE<br />

TUMOURS IN CHILDREN AND YOUTH - CLINICAL EXPERIENCE<br />

Wojciech Wozniak<br />

DELAY IN PRESENTATION AND TREATMENT OF PATIENTS WITH CONFIRMED OSTEOSARCOMA TO A SINGLE<br />

SOUTH AFRICA INSTITUTION<br />

David Reynders<br />

HYPOXIA -INDUCED CYTOTOXIC DRUG RESISTANCE IN OSTEOSARCOMA IS INDEPENDENT OF HIF-1 ALPHA<br />

Jennifer Adamski<br />

THE ONCOLYTIC ADENOVIRUS DELTA-24-RGD INDUCES A POTENT ANTITUMOR EFFECT IN VITRO AND IN<br />

VIVO IN PEDIATRIC OSTEOSARCOMA<br />

Ana Patiño-Garcia<br />

ACTIVATED NK CELLS EFFICIENTLY ELIMINATE EWING SARCOMA CELLS IN A SPHERE MODEL OF<br />

MICROMETASTATIC TUMOUR GROWTH<br />

Katharina Leuchte<br />

SERUM IGF-I LEVELS IN PATIENTS WITH HIGH-GRADE CENTRAL OSTEOSARCOMA ARE NOT CORRELATED TO<br />

PROGNOSIS<br />

Miriam Wilhelm<br />

MMP9 GENE EXPRESSION IN THE PERIPHERAL BLOOD: A POTENTIAL MARKER FOR MONITORING THE<br />

METASTATIC DISEASE IN OSTEOSARCOMA<br />

Carolina Salinas-Souza<br />

CYTOLYTIC NK CELL INTERACTIONS WITH EWING SARCOMA CELLS IN THE PRESENCE OF ZOLEDRONIC ACID<br />

Sarah-Kristin Mueller<br />

CHARACTERISATION OF GENES CRITICAL FOR CHONDRO-OSSEOUS DIFFERENTIATION, METASTASIS AND<br />

OSTEOTROPISM IN EWING TUMOURS<br />

Guen<strong>the</strong>r H.S. Richter<br />

FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING CONTROLS CANCER CELL SURVIVAL<br />

Ling Ling<br />

PD009<br />

PD010<br />

PD011<br />

PD012<br />

PD013<br />

PD014<br />

PD015<br />

PD016<br />

PD017<br />

PD018<br />

PD019<br />

PD020<br />

PD021<br />

PD022<br />

PD023<br />

Poster sessions

Poster sessions<br />

Poster Topic: Neuroblastoma + Renal Tumours - Session 1<br />

Moderator: Lisa Diller<br />

PH001 - PH023<br />

THE ROLE OF IMAGING IN DETECTING RELPASE IN PATIENTS WITH NEUROBLASTOMA. CAN POST-THERAPY<br />

SURVEILLANCE PROGRAMS BE SIMPLIFIED TO DECREASE RADIATION EXPOSURE?<br />

Cormac Owens<br />

COMPARISON OF PAIRED 123I-META IODOBENZYLGUANIDINE SCINTIGRAPHY AND 18F<br />

FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY SCANS BEFORE<br />

AND AFTER 131I-META IODOBENZYLGUANIDINE THERAPY FOR NEUROBLASTOMA<br />

Jennifer E Gains<br />

F18 FDG PET/CT: A POSSIBLE ONE STOP SHOP FOR STAGING OF NEUROBLASTOMA<br />

Purna Kurkure<br />

PEDIATRIC REFERENCE RANGES FOR PLASMA FREE METANEPHRINES AND THEIR RELEVANCE IN<br />

DIAGNOSIS OF NEUROBLASTOMA<br />

Maja Beck Popovic<br />

APPLICATION OF REAL-TIME PCR AND FLOW CYTOMETRY TECHNIQUES FOR BONE MARROW INVOLVEMENT<br />

ASSESSMENT IN NEUROBLASTOMA PATIENTS<br />

Alexander Druy<br />

ETHNIC DIFFERENCES IN NEUROBLASTOMA GENETICS INDICATED BY HIGH FREQUENCY OF ALK MUTATIONS IN<br />

VIETNAMESE TUMOURS: IDENTIFICATION OF EIGHT NOVEL TYROSINE KINASE DOMAIN MISSENSE MUTATIONS<br />

Niloufar Javanmardi<br />

ALK ACTIVATING INFANT NEUROBLASTOMA CASES INCLUDING MASS-SCREENING DETECTED CASES<br />

Masumi Kawashima<br />

METHYLATION STATUS IN NEUROBLASTOMA AND ITS PROGNOSTIC VALUE<br />

Adela Cañete<br />

TARGET EPIGENETIC REGULATION AT A SPECIFIC GENOMIC REGION TO INDUCE STEM CELL LIKE<br />

PHENOTYPE IN NEUROBLASTOMA CELLS<br />

Hiroki Nagase<br />

HDAC11 CONTROLS MITOTIC CELL CYCLE PROGRESSION OF NEUROBLASTOMA CELLS<br />

Theresa M. Thole<br />

EPIGENETIC DRUG COMBINATION INDUCES GENOME-WIDE DEMETHYLATION AND ALTERED GENE<br />

EXPRESSION IN NEURO-ECTODERMAL CELL LINES<br />

Max M. van Noesel<br />

NEUROBLASTOMA STAGE 4S IS A MULTIFOCAL STEM CELL DISEASE OF DEFECTED NEURAL CREST<br />

PRECURSER CELLS<br />

Max M. van Noesel<br />

FUNCTIONALLY ACTIVE MYELOID DERIVED SUPPRESSOR CELLS (MDSCS) ARE FOUND WITHIN THE BLOOD<br />

OF PATIENTS WITH NEUROBLASTOMA<br />

Katie Pearson<br />

THE TH-MYCN MOUSE MODEL FOR IMMUNOTHERAPEUTICAL STUDIES INTO NEUROBLASTOMA<br />

Peter Hoogerbrugge<br />

EPITHELIAL TO MESENCHYMAL TRANSITION AND TUMOUR PROGRESSION IN NEUROBLASTOMA<br />

Hiroaki Komuro<br />

Poster Board No<br />

PH001<br />

PH002<br />

PH003<br />

PH004<br />

PH005<br />

PH006<br />

PH007<br />

PH008<br />

PH009<br />

PH010<br />

PH011<br />

PH012<br />

PH013<br />

PH014<br />

PH015

NLRR3 IS NEGATIVELY REGULATED BY MYCN AND ITS DOWN-REGULATION IS ASSOCIATED WITH THE<br />

PATIENTS´ POOR OUTCOME IN NEUROBLASTOMA<br />

Atsushi Takatori<br />

UPREGULATION OF GENES INVOLVED IN TGFB/BMP SIGNALING IS CHARACTERISTIC FOR INVASIVE<br />

NEUROBLASTOMA<br />

Dietrich von Schweinitz<br />

FTY720 INHIBITS TUMOUR GROWTH AND ENHANCES THE TUMOUR-SUPPRESSIVE EFFECT OF TOPOTECAN<br />

IN NEUROBLASTOMA BY INTERFERENCE WITH SPHINGOSINE KINASE 2<br />

Mei-Hong Li<br />

LOW-DOSE ASPIRIN TREATMENT TARGETS TUMOUR-PROMOTING INFLAMMATION IN NEUROBLASTOMA<br />

AND INHIBITS AGGRESSIVE TUMOUR GROWTH IN VIVO<br />

Per Kogner<br />

A THREE-GENE EXPRESSION SIGNATURE MODEL FOR RISK STRATIFICATION OF PATIENTS WITH<br />

NEUROBLASTOMA<br />

Idoia Garcia<br />

TREATMENT OUTCOME OF DIFFERENT MAINTENANCE THERAPEUTIC METHODS IN CHINESE HIGH-RISK<br />

STAGE IV NEUROBLASTOMA<br />

Xia<strong>of</strong>ei Sun<br />

PHASE II STUDY OF THE COMBINATION OF BEVACIZUMAB PLUS IRINOTECAN AND TEMOZOLOMIDE FOR<br />

RELAPSED OR REFRACTORY NEUROBLASTOMA: PRELIMINARY RESULTS<br />

Shakeel Modak<br />

HIGH-RISK NEUROBLASTOMA WITH LOW MKI /11Q-LOSS AND MYCN NON-AMPLIFIED, HAS POOR PROGNOSIS<br />

OF DISEASE PROGRESSION; A PHASE II STUDY OF JAPAN NEUROBLASTOMA STUDY GROUP (JNBSG)<br />

Kimikazu Matsumoto<br />

Poster Topic: Neuroblastoma + Renal Tumours - Session 2<br />

Moderator: Akira Nakagawara<br />

PH024 - PH047<br />

LATE OUTCOMES IN SURVIVORS OF HIGH-RISK NEUROBLASTOMA<br />

Lisa Diller<br />

DISTINCT METASTATIC PATTERNS IN NEUROBLASTOMA ARE CORRELATED WITH MYCN AMPLIFICATION<br />

Gitta Bleeker<br />

EVALUATION OF SURGICAL RISK FACTORS INCLUDING IMAGE DEFINED RISK FACTORS FOR LOCALISED<br />

NEUROBLASTOMA<br />

Akihiro Yoneda<br />

NEUROBLASTOMA IN OLDER CHILDREN, ADOLESCENTS AND YOUNG ADULTS A REPORT FROM THE<br />

INTERNATIONAL NEUROBLASTOMA RISK GROUP PROJECT<br />

Yael P. Mosse<br />

MOLECULAR RADIOTHERAPY WITH MATIN: IODINE 131 META-IODOBENZYLGUANIDINE AND TOPOTECAN<br />

IN NEUROBLASTOMA. TOXICITY AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY<br />

NEUROBLASTOMA. A <strong>SIOP</strong>EN STUDY<br />

Mark N. Gaze<br />

FACTORS ASSOCIATED WITH RECURRENCE AND LENGTH OF SURVIVAL FOLLOWING RELAPSE IN PATIENTS<br />

WITH NEUROBLASTOMA: A PILOT STUDY<br />

Nermine Basta<br />

PH016<br />

PH017<br />

PH018<br />

PH019<br />

PH020<br />

PH021<br />

PH022<br />

PH023<br />

Poster Board No<br />

PH024<br />

PH025<br />

PH026<br />

PH027<br />

PH028<br />

PH029<br />

Poster sessions

Poster sessions<br />

A RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH HIGH-RISK<br />

NEUROBLASTOMA AFTER 1ST RECURRENCE: A REPORT FROM THE JAPAN NEUROBLASTOMA STUDY<br />

GRoUP<br />

Junichi Hara<br />

A PROSPECTIVE STUDY OF EXPECTANT OBSERVATION AS PRIMARY THERAPY FOR NEUROBLASTOMA IN<br />

YOUNG INFANTS, A CHILDREN’S ONCOLOGY GROUP STUDY<br />

Jed G. Nuchtern<br />

MINIMALLY INVASIVE SURGERY FOR NEUROGENIC TUMOURS IN CHILDREN: INDICATIONS ARE DEPENDING<br />

ON LOCATIONS AND IDRFS<br />

Irtan Sabine<br />

LONG TERM COMPLICATIONS IN CHILDREN TREATED FOR ADVANCED NEUROBLASTOMA<br />

Nathalia Halley<br />

RENAL TUMOURS IN ADOLESCENTS AND ADULTS: A RETROSPECTIVE ANALYSIS OF PATIENTS TREATED<br />

ACCORDING TO <strong>SIOP</strong> PROTOCOLS IN GERMANY<br />

Nasenien Nourkami-Tutdibi<br />

RHABDOID TUMOURS OF THE KIDNEY: A RETROSPECTIVE ANALYSIS OF PATIENTS TREATED IN GERMANY<br />

Nasenien Nourkami-Tutdibi<br />

TREATMENT OF NEPHROBLASTOMA IN AFRICA: WHICH ONE AND AT WHAT COST?<br />

Daniela Cristina Stefan<br />

TREATMENT OF NEPHROBLASTOMA IN SENEGAL<br />

Claude Moreira<br />

EPIDEMIOLOGIC AND CLINICAL CHARACTERISTICS OF WILMS TUMOUR IN MEXICO. EXPERIENCE AT<br />

INSTITUTO NACIONAL DE PEDIATRÍA<br />

Araceli Castellanos-Toledo<br />

OUTCOMES OF WILM’S TUMOUR IN INDIA: FINDINGS FROM A SYSTEMATIC ANALYSIS<br />

Bindu Koodiyedath<br />

WOULD FURTHER REFINEMENT IN MANAGEMENT OF WILMS TUMOUR HAVE AN IMPACT ON OUTCOME?<br />

Taha Mahmoud Khattab<br />

PATIENTS WITH NEPHROBLASTOMA TREATED WITH <strong>SIOP</strong> 2001 PROTOCOL IN NATIONAL HOSPITAL OF<br />

PEDIATRICS, HANOI, VIETNAM<br />

Hau Duc Tran<br />

BILATERAL WILMS TUMOUR (BWT). ONE CENTER EXPERIENCE<br />

Agnieszka Brozyna<br />

FAVOURABLE HISTOLOGY WILMS’ TUMOUR: A REVIEW OF 6 YEARS DATA FROM KING FAISAL SPECIALIST<br />

HOSPITAL AND RESEARCH CENTRE (KFSHRC), RIYADH, SAUDI ARABIA<br />

Ibrahim Mohamed Alfawaz<br />

TREATMENT OF WILMS TUMOUR (WT) WITHIN THE CENTRAL AMERICAN ASSOCIATION OF PEDIATRIC<br />

HEMATOLOGY/ONCOLOGY (AHOPCA); REPORT FROM GUATEMALA, HONDURAS, EL SALVADOR, AND<br />

NICARAGUA: IMPROVING RESULTS BY CHANGING STRATEGY NOT THERAPY<br />

Patricia Valverde<br />

THE ROLE OF FINE NEEDLE ASPIRATION CYTOLOGY IN EVALUATION OF PAEDIATRIC ABDOMINAL MASSES:<br />

INDICATIONS, CONTRAINDICATIONS, BENEFITS AND COMPLICATIONS SEEN OVER 8 YEARS AND 276 ASPIRATIONS<br />

Venkateswaran K. Iyer<br />

PH030<br />

PH031<br />

PH032<br />

PH033<br />

PH034<br />

PH035<br />

PH036<br />

PH037<br />

PH038<br />

PH039<br />

PH040<br />

PH041<br />

PH042<br />

PH043<br />

PH044<br />

PH045

LONG-TERM RENAL FUNCTION IN PATIENTS NEPHRECTOMISED FOR UNILATERAL RENAL TUMOUR:<br />

CROSS-SECTIONAL STUDY<br />

Amalia Schiavetti<br />

DEFECTS IN THE DNA MISMATCH REPAIR SYSTEM DO NOT CONTRIBUTE TO THE DEVELOPMENT OF<br />

CHILDHOOD WILMS TUMOURS<br />

Heidi Segers<br />

Poster Topic: S<strong>of</strong>t tissue sarcomas, Retinoblastoma + Liver Tumours<br />

Moderator: Meriel Jenney<br />

PI001 - PK006<br />

REDUCED CYCLES OF SYSTEMIC CHEMOTHERAPY WITH FOLLOWING MORE FOCUSED LOCAL TREATMENTS<br />

FOR INTRAOCULAR RETINOBLASTOMA<br />

Masaharu Akiyama<br />

CRANIO-FACIAL SECOND PRIMARY TUMOURS IN RETINOBLASTOMA PATIENTS PREVIOUSLY TREATED BY<br />

RADIATION THERAPY: A MULTICENTER CLINICAL AND RADIOLOGICAL STUDY OF 42 PATIENTS<br />

Pim de Graaf<br />

SPORADIC UNILATERAL RETINOBLASTOMA OR FIRST SIGN OF BILATERAL DISEASE?<br />

Petra Temming<br />

OCULAR SURVIVAL IN PATIENTS WITH UNILATERAL RETINOBLASTOMA - SINGLE INSTITUTIONS EXPERIENCE<br />

Olga Rutynowska<br />

RETINOBLASTOMA. RECENT EXPERIENCE AT CASABLANCA UNIVERSITY HOSPITAL<br />

Siham Cherkaoui<br />

SURVIVAL FROM RETINOBLASTOMA IN RURAL UGANDA<br />

Keith Waddell<br />

PRIMARY DIAGNOSIS OF RETINOBLASTOMA OVER TIME A SINGLE CENTER EXPERIENCE IN A MEXICAN<br />

INSTITUTION<br />

Carlos A. Leal<br />

ROLE OF POLYCOMB PROTEINS EZH2 AND BMI-1 IN PATHOGENESIS OF PEDIATRIC SOLID TUMOURS<br />

Velia D’Angelo<br />

EXPRESSION AND GENOMIC STATUS OF ALK RECEPTOR TYROSINE KINASE IN ALVEOLAR AND EMBRYONAL<br />

RHABDOMYOSARCOMA<br />

Paolo Bonvini<br />

VALIDATION OF SERUM MIR-206 EXPRESSION LEVEL AS A DIAGNOSTIC BIOMARKER FOR<br />

RHABDOMYOSARCOMA: A REPORT OF THE CHILDREN’S ONCOLOGY GROUP STUDY ARST12B1<br />

Mitsuru Miyachi<br />

SARCOMA CELLS MIMIC IMMUNOSUPPRESSIVE MECHANISM OF MESENCHYMAL STEM CELLS BY T CELL<br />

INHIBITION IN AN INDOLAMINE 2,3-DIOXYGENASE DEPENDENT MANNER<br />

Daniela Topolar<br />

TARGETED THERAPEUTIC APPROACHES IN ADVANCED DESMOPLASTIC SMALL ROUND CELL TUMOUR<br />

INCLUDING PAZOPANIB, PEG INTERFERON AND IGFR INHIBITORS<br />

Peter Meade Anderson<br />

PH046<br />

PH047<br />

Poster Board No<br />

PI001<br />

PI002<br />

PI003<br />

PI004<br />

PI005<br />

PI006<br />

PI007<br />

PJ001<br />

PJ002<br />

PJ003<br />

PJ004<br />

PJ005<br />

Poster sessions

Poster sessions<br />

HOW CRITICAL IS THE PATHOLOGY REVIEW OF PEDIATRIC SARCOMA REFERRED TO A CANCER CENTER IN A<br />

DEVELOPING COUNTRY<br />

Taleb M. Ismael<br />

EXTRASKELETAL EWING’S SARCOMA (EES) AND SKELETAL EWING’S SARCOMA - ARE THEY DIFFERENT ENTITIES?<br />

Sameer Rastogi<br />

MULTIDISCIPLINARY APPROACH INCLUDING EXTENSIVE SURGERY OF PTERYGOPALATINE/INFRATEMPORAL<br />

FOSSA SOFT TISSUE SARCOMA<br />

Véronique Minard-Colin<br />

OUTCOME OF INFLAMMATORY MYOFIBROBLASTIC TUMOURS (IFM) REGISTERED ON THE EPSSG NRSTS<br />

2005 STUDY<br />

Bernadette Brennan<br />

CLINICAL PROFILE AND OUTCOMES OF RHABDOMYOSARCOMA PATIENTS TREATED AT TATA MEMORIAL<br />

HOSPITAL: A RETROSPECTIVE ANALYSIS<br />

Sourabh Radhakrishnan<br />

SYNOVIAL SARCOMA: REPORT OF A SERIES OF 30 CHILDREN AND ADOLESCENTS FROM A SINGLE<br />

INSTITUTION<br />

Sima Ferman<br />

ALVEOLAR SOFT PART SARCOMA: RADIOLOGICAL PATTERN IN CHILDREN AND ADOLESCENTS<br />

Herve J. Brisse<br />

MECHANISM OF WNT SIGNAL PATHWAY ACTIVATION IN HEPATOBLASTOMA<br />

Yuka Ueda<br />

EXPRESSION OF GATA4 IN EPITHELIAL LIVER TUMOURS IN CHILDREN AND ADOLESCENTS<br />

Patrizia Dall’Igna<br />

PRELIMINARY EXPERIENCE USING HIGH INTENSITY FOCUSED ULTRASOUND COMBINED WITH<br />

TRANSCATHETER ARTERIAL EMBOLIZTION FOR THE TREATMENT OF CHILDREN WITH ADVANCED<br />

HEPATOBLASTOMA<br />

Shan Wang<br />

HEPATOCARCINOMA IN CHILDREN: 13 YEARS EXPERIENCE OF A PEDIATRIC ONCOLOGY GROUP IN PERU<br />

Ana Gloria Paredes Guerra<br />

HEPATOBLASTOMA ASSOCIATED WITH BECKWITH-WIEDEMANN SYNDROME IN JAPAN: THE JPLT<br />

EXPERIENCE<br />

Kenichiro Watanabe<br />

PEDIATRIC LIVER TUMOURS IN THE DEVELOPING WORLD: A LONG WAY TO GO<br />

Nivedita Dhingra<br />

Poster Topic: Rare tumours<br />

Moderator: Peter Adamson<br />

PL001 - PL019<br />

ADRENOCORTICAL TUMOURS IN CHILDREN: A 25 YEAR EXPERIENCE<br />

Akiko Sakoda<br />

CLASS II HISTOCOMPATIBILITY ANTIGENS (HLA) IN CHILDHOOD ADRENOCORTICAL TUMOURS (ACT): LOW<br />

EXPRESSION IS RELATED WITH POOR PROGNOSIS<br />

Carlos Alberto Scrideli<br />

PJ006<br />

PJ007<br />

PJ008<br />

PJ009<br />

PJ010<br />

PJ011<br />

PJ012<br />

PK002<br />

PK003<br />

PK004<br />

PK005<br />

PK006<br />

Poster Board No<br />

PL001<br />

PL002

OVEREXPRESSION OF IGF1R BUT NOT IGF2 IS ASSOCIATED WITH UNFAVOURABLE EVENT AND METASTASIS<br />

IN ADRENOCORTICAL CARCINOMAS<br />

Regia Caroline Peixoto Lira<br />

ENDOGLIN AS A PROGNOSTIC MARKER IN PEDIATRIC ADRENOCORTICAL TUMOURS<br />

André Ivan Bradley Santos Dias<br />

DIFFERENTIAL MICRORNAS EXPRESSIONS ARE ASSOCIATED WITH RELAPSE AND TP53 P.R377H MUTATION<br />

IN PEDIATRICS ADRENOCORTICAL TUMOURS<br />

Paola Fernanda Fedatto<br />

PRIMARY METASTASIS AND RELAPSES IN ADRENAL CORTICOCARCINOMA IN CHILDREN: AN OVERVIEW<br />

FROM A SINGLE INSTITUTION<br />

Tais Junqueira<br />

CLINICAL CHARACTERISTICS AND EPIDEMIOLOGY OF GASTROINTESTINAL ADENOCARCINOMAS IN<br />

CHILDREN: EXPERIENCE IN SOLCA HOSPITAL, QUITO<br />

Erika Villanueva<br />

LYMPHANGIOGENESIS IN PEDIATRIC ADRENOCORTICAL TUMOURS<br />

Camila Girardi Fachin<br />

FOLLOW-UP OF CHILDREN WITH GENETIC MUTATION FOR ADRENOCORTICAL TUMOURS IN WESTERN<br />

PARANÁ<br />

Carmem Mendonça Fiori<br />

K-RAS MUTATION AND COLORECTAL CARCINOMA IN CHILDHOOD<br />

Canan Akyuz<br />

TITLE: RETROSPECTIVE ANALYSIS OF HISTOLOGY AND EVALUATION OF PROGNOSTIC MARKERS OF<br />

PANCRETOBLASTOMA<br />

Mukta Ravindra Ramadwar<br />

EXOME SEQUENCING REVEALS GENETIC PREDIPOSITION IN PEDIATRIC COLORECTAL CANCER<br />

Marjolijn Jongmans<br />

INFANTILE MYOFIBROMATOSIS IN IDENTICAL TWINS AND THEIR PROGENY WITH A VARIABLE PATTERN OF<br />

INHERITANCE: A REPORT OF 4 PATIENTS<br />

Ketan Kulkarni<br />

MYOEPHITELIAL CARCINOMA OF THE SOFT TISSUE IN PEDIATRIC AGE. A REPORT FROM THE TREP PROJECT<br />

Gianni Bisogno<br />

CAN WE USE THE TORONTO EXTREMITY SALVAGE SCORE TO MEASURE FUNCTIONAL OUTCOME IN<br />

PAEDIATRIC DESMOID FIBROMATOSIS?<br />

Gurhan Erturan<br />

NEUROENDOCRINE TUMOURS IN CHILDREN AND YOUNG ADULTS: THE M. D. ANDERSON CANCER CENTER<br />

EXPERIENCE<br />

Ca<strong>the</strong>rine H. Boston<br />

NON-AIDS DEFINED MALIGNANCIES AMONG CHILDREN LIVING WITH HIV/AIDS IN UGANDA AND CO-<br />

ASSOCIATION WITH HHV-8 AND EBV<br />

Jozef Suvada<br />

COMPLICATIONS AFTER THYROIDECTOMY AND NECK DISSECTION IN CHILDREN WITH THYROID CARCINOMA<br />

Vladimir Polyakov<br />

OSTEOPONTIN AS A POTENTIAL CLINICAL TUMOUR MARKER FOR CHILDHOOD CANCER<br />

Nasenien Nourkami-Tutdibi<br />

PL003<br />

PL004<br />

PL005<br />

PL006<br />

PL007<br />

PL008<br />

PL009<br />

PL010<br />

PL011<br />

PL012<br />

PL013<br />

PL014<br />

PL015<br />

PL016<br />

PL017<br />

PL018<br />

PL019<br />

Poster sessions

Poster sessions<br />

Poster Topic: Brain tumours – Session 1<br />

Moderator: Stefan Josef Rutkowski<br />

PM001 - PM029<br />

BRAIN TUMOUR IN CHILDHOOD: THE IMPACT OF CRANIAL IRRADIATION AND TUMOUR LOCATION ON<br />

FERTILITY<br />

Anja Borgmann<br />

IS IT TIME TO REVISE THE RECIST CRITERIA TO INCORPORATE STEREOLOGY? A COMPARATIVE STUDY OF<br />

MANUAL PLANIMETRY, CALLIPER MEASUREMENTS AND MODERN STEREOLOGICAL METHODS IN THE<br />

MEASUREMENT OF TUMOUR SIZE IN PAEDIATRIC BRAIN TUMOUR IMAGING<br />

Amy Mitchell<br />

AN EXPERIMENTAL XENOGRAFT MOUSE MODEL OF DIFFUSE INFILTRATING PONTINE GLIOMA<br />

Yasuyuki Aoki<br />

THREE YEAR VISUAL OUTCOMES AFTER CHEMOTHERAPY FOR NF1 OPTIC PATHWAY GLIOMAS IN CHILDREN<br />

Michael J. Fisher<br />

EXCELLENT LONG-TERM VISUAL PROGNOSIS FOLLOWING CHEMOTHERAPY FOR NF1 ASSOCIATED OPTIC<br />

PATHWAYS GLIOMAS WITH NORMAL BASELINE VISUAL ACUITY<br />

Michael J. Fisher<br />

CONCURRENT MEK AND BRAF INHIBITION IN BRAF-MUTANT PEDIATRIC ASTROCYTOMAS: INCREASED<br />

EFFICACY WITH DECREASED RISK OF SECONDARY MALIGNANCIES<br />

Theodore Nicolaides<br />

CHEMOKINE EXPRESSION IN PAEDIATRIC HIGH GRADE GLIOMA IS INFLUENCED BY THE TUMOUR<br />

MICROENVIRONMENT AND DIFFERS FROM ADULT HIGH GRADE GLIOMA<br />

Yvonne Majani<br />

EARLY NEUROCOGNITIVE SCREENING FOR PEDIATRIC BRAIN TUMOUR PATIENTS<br />

Cynthia Karlson<br />

IN VIVO EVALUATION OF THE PATHOGENIC AND THERAPEUTIC RELEVANCE OF BRAF FUSION GENE<br />

VARIANTS IN JUVENILE PILOCYTIC ASTROCYTOMA<br />

Huriye Cin<br />

ATTENTION NETWORKS IN PEDIATRIC BRAIN TUMOUR SURVIVORS<br />

Marieke A. de Ruiter<br />

FEASIBILITY OF LONG-TERM INTRAVENTRICULAR THERAPY ALTERNATING ETOPOSIDE AND LIPOSOMAL<br />

CYTARABINE: EXPERIENCE IN 41 CHILDREN WITH MALIGNANT BRAIN TUMOURS<br />

Irene Slavc<br />

ACTINOMYCIN-D TREATMENT OF HIGH-RISK EPENDYMOMAS REACTIVATES P53 AND MEDIATES P53-<br />

RELATED EFFECTS<br />

Theophilos D. Tzaridis<br />

CHANGES IN THE PATTERNS OF CARE OF CENTRAL NERVOUS SYSTEM TUMOURS AMONG 16-24 YEAR OLDS<br />

AND THE IMPACT ON SURVIVAL IN YORKSHIRE BETWEEN 1990-2009<br />

Brian Nicholson<br />

TREATMENT OF YOUNG CHILDREN WITH DISSEMINATED MEDULLOBLASTOMA TREATED ACCORDING THE<br />

PROSPECTIVE MULTICENTER TRIAL HIT 2000<br />

Stefan Rutkowski<br />

AURORA KINASE INHIBITION DECREASES PROLIFERATION AND DIMINISHES CLONOGENIC CAPACITY IN<br />

PEDIATRIC MEDULLOBLASTOMA CELL LINES<br />

Lenisa Geron<br />

Poster Board No<br />

PM001<br />

PM002<br />

PM003<br />

PM004<br />

PM005<br />

PM006<br />

PM007<br />

PM008<br />

PM009<br />

PM010<br />

PM011<br />

PM012<br />

PM013<br />

PM014<br />

PM015

CARBOPLATIN AND VINCRISTINE AS TREATMENT FOR PROGRESSIVE HYPOTHALAMIC/OPTIC PATHWAY<br />

GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND RISK OF SECOND MALIGNANT<br />

NEOPLASMS: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP (COG)<br />

Joann Ater<br />

A PROSPECTIVE STUDY OF CEREBRAL, FRONTAL LOBE AND TEMPORAL LOBE VOLUME AND<br />

NEUROPSYCHOLOGIC PERFORMANCE IN CHILDREN WITH PRIMARY BRAIN TUMOURS TREATED WITH<br />

CRANIAL RADIATION<br />

Harold Agbahiwe<br />

A PROPOSED DESIGN FOR A <strong>SIOP</strong>-E TRIAL IN OPTIC PATHWAY GLIOMA (OPG) ASSOCIATED WITH<br />

NEUROFIBROMATOSIS TYPE 1 (NF1)<br />

Andrew Howman<br />

FEASIBILITY, TOXICITY AND PRELIMINARY RESULTS OF HELICAL TOMOTHERAPY IN PEDIATRIC<br />

MEDULLOBLASTOMA<br />

Maribel Bruna Figueroa<br />

DIFFUSE INTRINSIC PONTINE GLIOMAS IN CHILDREN: RESULTS FROM A SINGLE CENTER<br />

Rejin Kebudi<br />

INITIAL HYPOTHALAMIC INVOLVEMENT IS A MAJOR RISK FACTOR FOR IMPAIRED PROGNOSIS AND QUALITY<br />

OF LIFE IN CHILDHOOD CRANIOPHARYNGIOMA REGARDLESS OF CHOSEN TREATMENT STRATEGIES -<br />

RESULTS OF KRANIOPHARYNGEOM 2000<br />

Hermann Lothar Müller<br />

<strong>SIOP</strong> CHOROID PLEXUS TUMOUR INITIATIVE - INTERIMS REPORT <strong>2012</strong><br />

Johannes Wolff<br />

PROTON THERAPY FOR LOW GRADE GLIOMA: EARLY CLINICAL OUTCOMES<br />

Daniel J Indelicato<br />

PHASE 2, SINGLE ARM TRIAL OF IRINOTECAN AND CISPLATIN IN CHILDREN WITH HIGH-RISK GLIOMAS<br />

Ofelia Cruz<br />

NEW POTENTIAL THERAPEUTIC TARGETS FOR ATIPICAL TERATOID/RHABDOID TUMOURS (ATRT)<br />

Simone Treiger Sredni<br />

PHARMOCOKINETICS OF INTRATHECAL LIPOSOMAL CYTARABINE IN CHILDREN OF DIFFERENT AGE GROUPS<br />

Andreas Peyrl<br />

ANAPLASTIC EPENDYMOMA. RESULTS FROM POLISH PEDIATRIC NEUROONCOLOGY GROUP<br />

Danuta Perek<br />

PRIMARY CNS TUMOURS IN CHILDREN AND ADOLESCENTS. OWN EXPERIENCE<br />

Bozena Dembowska-Baginska<br />

Poster Topic: Brain tumours – Session 2<br />

Moderator: Francois Doz<br />

PM030 - PM058<br />

ANALYSES OF CANCER INCIDENCE AND CAUSES OF DEATH IN CHILD-PARENT TRIOS: CLUES TO AETIOLOGY<br />

OF CHILDHOOD CENTRAL NERVOUS SYSTEM (CNS) TUMOURS<br />

Robert David Alston<br />

MANAGEMENT OF CRANIOPHARYNGIOMA: THE LIVERPOOL EXPERIENCE FOLLOWING INTRODUCTION OF<br />

CCLG GUIDELINES. INTRODUCING A NEW RISK ASSESSMENT GRADING SYSTEM<br />

Barry Pizer<br />

PM016<br />

PM017<br />

PM018<br />

PM019<br />

PM020<br />

PM021<br />

PM022<br />

PM023<br />

PM024<br />

PM025<br />

PM026<br />

PM027<br />

PM028<br />

Poster Board No<br />

PM029<br />

PM030<br />

Poster sessions

Poster sessions<br />

THE ROLE OF SURGERY IN OPTIC PATHWAY & CHIASMATIC-HYPOTHALAMIC GLIOMAS IN CHILDREN<br />

Barry Pizer<br />

TRANSCRIPTIONAL PROFILES OF MEDULLOBLASTOMA TUMOURS: CORRELATION WITH CLINICAL AND<br />

HISTOPATHOLOGICAL FEATURES. AN EXPERIENCE FROM A SINGLE INSTITUTION<br />

Maria Łastowska<br />

EFFECTS OF RESVERATROL AND 5-AZA-2’DEOXYCYTIDIN ON DOUBLE-STRAND BREAK REPAIR AND<br />

CLONOGENIC SURVIVAL AFTER IRRADIATION OF HUMAN MEDULLOBLASTOMA CELL LINES<br />

Ina Patties<br />

15 YEARS OF PEDIATRIC NEURO-ONCOLOGY IN POLAND<br />

Danuta Perek<br />

TREATMENT RESULTS OF METASTATIC MEDULLOBLASTOMA (M2 AND M3 ACCORDING TO CHANG<br />

CLASSIFICATION) IN CHILDREN OVER 3 YEARS OF AGE. EXPERIENCE FROM ONE INSTITUTION<br />

Marta Perek-Polnik<br />

CHANGING FAILURE PATTERN WITH CHANGING RADIOTHERAPY TARGET VOLUME IN EPENDYMOMA?<br />

Anne-Sophie Carret<br />

THE TREATMENT OF AVERAGE RISK MEDULLOBLASTOMA WITH CHEMOTHERAPY, REDUCED DOSE<br />

CRANIOSPINAL IRRADIATION, AND TUMOUR BED ONLY BOOST: THE UNIVERSITY OF WASHINGTON<br />

EXPERIENCE 1990 - 2008<br />

James Gordon Douglas<br />

MISMATCH REPAIR DEFICIENCY: A TEMOZOLOMIDE RESISTANCE FACTOR IN MEDULLOBLASTOMA CELL<br />

LINES WHICH IS UNCOMMON IN PRIMARY MEDULLOBLASTOMA TUMOURS<br />

André O. von Bueren<br />

MEDULLOBLASTOMA CELL LINE EXPOSED TO HYPOXIA ENVIRONMENT AND MIMETIC REAGENTS<br />

EXPRESSES HIF1A AND VEGF WITHOUT AFFECTING CELL VIABILITY<br />

Gustavo Alencastro Veiga Cruzeiro<br />

MULTICENTRIC PHASE I STUDY OF CILENGITIDE (CGT) IN COMBINATION WITH RADIATION THERAPY IN<br />

CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA: PRELIMINARY RESULTS<br />

Pierre Leblond<br />

OPTIC PATHWAY GLIOMA; INDICATIONS OF TREATMENT<br />

Ian Simmons<br />

MICRORNA SIGNATURES IN A BROAD COHORT OF PAEDIATRIC BRAIN TUMOURS<br />

Jennie N Jeyapalan<br />

THE EFFICACY OF COMBINATION OF BEVACIZUMAB AND TEMOZOLOMIDE IN CHILDREN WITH PRIMARY<br />

HIGH-GRADE CNS-GLIOMAS<br />

Boris Vladimirovich Kholodov<br />

DHMEQ INHIBITS IN VITRO MIGRATION AND INVASION IN ADULT AND PEDIATRIC GLIOBLASTOMA CELLS<br />

Lara Elis Alberici Delsin<br />

DUAL CONTRAST PERFUSION MRI IN A SINGLE IMAGING SESSION FOR ASSESSMENT OF PEDIATRIC BRAIN<br />

TUMOURS<br />

Edward A Neuwelt<br />

TREATMENT OF EXTRANEURAL MEDULLOBLASTOMA - A REVIEW AND SURVEY OF UK ONCOLOGY PRACTICE<br />

Martin G McCabe<br />

PM031<br />

PM032<br />

PM033<br />

PM034<br />

PM035<br />

PM036<br />

PM037<br />

PM038<br />

PM039<br />

PM040<br />

PM041<br />

PM042<br />

PM043<br />

PM044<br />

PM045<br />

PM046

IMMUNOTHERAPY FOR (RELAPSED) GBM WITH AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOUR<br />

LYSATE: CURRENT CLINICAL EXPERIENCES<br />

Stefaan Willy Van Gool<br />

CNS GERMINOMA IN CHILDREN: THE OPTIMISATION OF COMBINED THERAPY<br />

Ekaterina Mikhailovna Tarasova<br />

OUTCOMES OF RADIOTHERAPY ALONE VS. CHEMOTHERAPY FOLLOWED BY RESPONSE-BASED<br />

RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CNS GERMINOMA (COG ACNS 0232)<br />

Stephen Sands<br />

FORMALISED DESCRIPTIVE SET DECISION TREE CLASSIFICATION OF PAEDIATRIC POSTERIOR FOSSA<br />

TUMOURS<br />

Stavros Michael Stivaros<br />

NUTRITIONAL STATUS IN CHILDREN WITH HIGH-RISK BRAIN TUMOUR - DIAGNOSTIC AND THERAPEUTIC<br />

POSSIBILITIES<br />

Jasminka Stepan Giljevic<br />

ZEBULARINE PROMOTES RADIOSENSITIVITY IN GLIOBLASTOMA AND IS LESS CYTOTOXIC THAM<br />

TEMOZOLOMIDE<br />

Daniel Antunes Moreno<br />

HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) WITH CHEMOTHERAPY FOR M 1-3<br />

MEDULLOBLASTOMA (MB) - A CHILDREN’S CANCER AND LEUKAEMIA GROUP(CCLG)/NATIONAL CANCER<br />

RESEARCH NETWORK (NCRN) STUDY<br />

Roger Taylor<br />

NATURAL KILLER CELL IMMUNOTHERAPY AGAINST MEDULLOBLASTOMA<br />

Antonio Pérez-Martínez<br />

PEDIATRIC GLIOMAS. ANALYSIS OF IDH1 MUTATIONS<br />

Mariona Suñol<br />

NOVEL BIOMARKERS OF PROGNOSIS FOR MEDULLOBLASTOMA USING 1H MAGNETIC RESONANCE<br />

SPECTROSCOPY<br />

Simrandip Kaur Gill<br />

SURGICAL PATHWAY AND MANAGEMENT OF PINEAL REGION TUMOURS IN CHILDREN<br />

Benedetta Pettorini<br />

SAFETY AND EFFICACY OF NIMOTUZUMAB IN THE TREATMENT OF CHILDREN AND ADOLESCENTS CENTRAL<br />

WITH MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS<br />

Ricardo Cabanas<br />

Poster Topic: Germ cell tumours<br />

Moderator: Carlos Galindo Rodrigues<br />

PM060 - PM072<br />

POOR RISK SURVIVAL<br />

Fernanda Abrantes<br />

TREATMENT OUTCOME OF CHILDREN WITH MALIGNANT GERM CELL TUMOUR--A REPORT OF 62 CASES<br />

Chao Yang<br />

PM047<br />

PM048<br />

PM049<br />

PM050<br />

PM051<br />

PM052<br />

PM053<br />

PM054<br />

PM055<br />

PM056<br />

PM057<br />

PM058<br />

Poster Board No<br />

PM060<br />

PM061<br />

Poster sessions

Poster sessions<br />

COMPLETELY RESECTED SACROCOCCYGEAL GERM CELL TUMOURS WITH FOCI OF YOLK SAC TUMOUR ARE<br />

CURED WITH SURGERY ALONE<br />

A. Frazier<br />

STAGE I GONADAL GERM CELL TUMOURS (GGCT): OUTCOME AFTER THE SURVEILLANCE STRATEGY AS<br />

APPLIED IN THE ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA (AIEOP) 2004 PROTOCOL<br />

Monica Terenziani<br />

TREATMENT OUTCOME OF EXTRA-CRANIAL GERM CELL TUMOUR IN CHINESE CHILDREN IN HONG KONG<br />

Rever Chak-Ho Li<br />

OUTCOME OF RELAPSED INTRACRANIAL GERM CELL TUMOURS FROM A SINGLE CHILDREN´S HOSPITAL<br />

Mei-Yoke Chan<br />

450K CHIP ANALYSIS SHOWS STRIKING DIFFERENCES IN METHYLATION BETWEEN DIFFERENT<br />

HISTOLOGICAL SUBTYPES OF GERM CELL TUMOUR<br />

Paul John Scotting<br />

REASSESSING THE ORIGINS OF INTRACRANIAL GERM CELL TUMOUR FORMATION<br />

Paul John Scotting<br />

TRATMENT AND OUTCOME OF EXTRACRANIAL GERM CELL TUMOURS IN CHILDREN: CAN<br />

MULTIDISCIPLINARY TEAM MANGEMENT IMPROVE SURVIVAL IN A DEVELOPING COUNTRY?<br />

Alia Ahmad<br />

IS THERE A ROLE FOR CARBOPLATIN IN THE TREATMENT OF MALIGNANT GERM CELL TUMOURS? A<br />

SYSTEMATIC REVIEW OF ADULT AND PEDIATRIC TRIALS<br />

Furqan Shaikh<br />

TREATMENT FAILURES AND RESULTS OF PROGRESSION/RELAPSE TREATMENT IN CHILDREN WITH<br />

EXTRACRANIAL GERM CELL TUMOURS - LONG-TERM SINGLE CENTER EXPERIENCE<br />

Katarzyna Wachowiak-Szajdak<br />

PRIMARY MEDIASTINAL NON SEMINOMATOUS MALIGNANT GCT (PMNSGCT) IN CHILDREN: FINAL LONG<br />

TERM RESULTS OF THE FRENCH SFOP/ SFCE TGM 95 PROTOCOL<br />

Cecile Verite<br />

GERM CELL TUMOUR: PRESENTING CHARACTERISTICS AND OUTCOME FROM A TERTIARY CANCER CARE<br />

CENTRE (INDIA)<br />

P. Dwivedi<br />

Poster Topic: New drugs/experimental <strong>the</strong>rapeutics<br />

Moderator: Bruce Morland<br />

PN001 - PN014<br />

A PHASE I STUDY OF VINBLASTINE AND SIROLIMUS IN PEDIATRIC PATIENTS WITH RECURRENT OR<br />

REFRACTORY SOLID TUMOURS INCLUDING CNS TUMOURS<br />

Monia Marzouki<br />

VALIDATION OF SRC FAMILY KINASES (SFKS) AND PHOSPHATIDYLINOSTOL 3-KINASES (PI-3KS)/MTOR AS<br />

DRUG TARGETS IN PAEDIATRIC OSTEOSARCOMA<br />

Shaun Villa<br />

SORAFENIB ENHANCES THE ANTITUMOUR EFFECT OF CHEMORADIATION TREATMENT ON HUMAN<br />

OSTEOSARCOMA CELLS<br />

Jun Ah Lee<br />

PM062<br />

PM063<br />

PM064<br />

PM065<br />

PM066<br />

PM067<br />

PM068<br />

PM069<br />

PM070<br />

PM071<br />

PM072<br />

Poster Board No<br />

PN001<br />

PN002<br />

PN003

EARLY PHASE CLINICAL TRIALS IN PAEDIATRIC ONCOLOGY. THE ROYAL MARSDEN EXPERIENCE<br />

Daniel Morgenstern<br />

POLO-LIKE KINASE 1 AS A POTENTIAL TARGET IN PEDIATRIC MEDULLOBLASTOMA<br />

Julia Alejandra Pezuk<br />

INHIBITION OF LIT1 GENE TRANSCRIPTION BY PYRROLE-IMIDAZOLE POLYAMIDE IN BECKWITH-WIEDEMANN<br />

SYNDROME FIBROBLAST CELL LINES<br />

Shinsuke Yoshizawa<br />

EFFICACY OF PROPANOLOL FOR TREATING INFANTILE HEMANGIOMAS AND DETERMINING DECLINE IN<br />

HEART RATE TO PREDICT RESPONSE TO PROPANOLOL<br />

Vishal Sondhi<br />

INTRATHECAL STEROIDS REDUCE THE SEVERITY AND FREQUENCY OF ADVERSE EVENTS ASSOCIATED WITH<br />

INTRATHECAL LIPOSOMAL CYTARABINE ADMINISTRATION IN CHILDREN WITH CANCER<br />

ALVARO LASSALETTA<br />

ZEBULARINE INDUCES CHEMOSENSITISATION TO METHOTREXATE AND EFFICIENTLY DECREASE AHR GENE<br />

METHYLATION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINES<br />

Augusto Faria Andrade<br />

DOUBLE ALKYLATING AGENTS TREATMENT WITH IFOSFAMIDE (IFOS) AND CYCLOPHOSPHAMIDE (CYCLO)<br />

FOR RELAPSED PEDIATRIC SOLID TUMOURS<br />

Sidnei Epelman<br />

THE EFFECT OF RESVERATROL ON ARA-C INDUCED CEREBELLAR TOXICITY<br />

Kamer Mutafoglu<br />

THE EFFECT OF MESENCHYMAL STEM CELLS AND RESVERATROL ON DOXORUBICIN CARDIOTOXICITY IN RATS<br />

Faruk Guclu Pinarli<br />

IRINOTECAN AND TEMOZOLAMIDE FOR CHILDREN WITH RELAPSED OR REFRACTORY RHABDOMYOSARCOMA,<br />

NEUROBLASTOMA AND EWING SARCOMA TUMOURS: EXPERIENCE IN A SINGLE CENTER<br />

Gimena Gil<br />

ROLE OF CYTOCHROME P450 ENZYMES IN THE METABOLIC FATE OF BUSULFAN AS EXPLORED IN PEDIATRIC<br />

PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION<br />

Chakradhara Rao Satyanarayana Uppugunduri<br />

Poster Topic: Epidemiology<br />

Moderator: Jillian Birch<br />

PP001 - PP031<br />

DEVELOPMENT OF CHILDHOOD CANCER DATABASES IN LOW-MIDDLE INCOME COUNTRIES<br />

Tim Eden<br />

EVALUATION OF PATIENTS WITH INTRACRANIAL TUMOURS PRESENTING WITH CENTRAL DIABETES INSIPIDUS<br />

Ali Varan<br />

TRENDS IN SURVIVAL AFTER DIAGNOSIS OF MALIGNANCY OF EGYPTIAN ADOLESCENT PATIENTS (10 YEARS<br />

SINGLE CENTER EXPERIENCE)<br />

Nayera H.K. Elsherif<br />

PN004<br />

PN005<br />

PN006<br />

PN007<br />

PN008<br />

PN009<br />

PN010<br />

PN011<br />

PN012<br />

PN013<br />

PN014<br />

Poster Board No<br />

PP001<br />

PP002<br />

PP003<br />

Poster sessions

Poster sessions<br />

ANALYSIS OF CHILDHOOD CANCER DEATHS - EXPERIENCE OF HOSPITAL AC CAMARGO<br />

Caroline Cabral Kanaan<br />

REASONS FOR DELAY IN TIME OF DIAGNOSIS TO START OF TREATMENT, FOR CHILDREN WITH CANCER<br />

ADMITTED TO MBINGO BAPTIST HOSPITAL, CAMEROON<br />

Francine Kouya<br />

NEONATAL CANCER IN GREAT BRITAIN. INCIDENCE AND SURVIVAL, 1988-2007<br />

Charles A. Stiller<br />

SECOND CANCERS OCCURRING WITHIN FIVE YEARS FROM INITIAL DIAGNOSIS OF CHILDHOOD CANCER<br />

Charles A. Stiller<br />

A SYSTEMATIC REVIEW OF THE DEFINITIONS AND METHODS USED TO INVESTIGATE DELAYS AND THE TIME<br />

TO DIAGNOSIS IN CHILDREN AND YOUNG ADULTS WITH CANCER<br />

Christopher Lethaby<br />

THE INFLUENCE OF BIRTH WEIGHT AND CONGENITAL MALFORMATIONS ON SURVIVAL FROM CHILDHOOD<br />

LYMPHOID LEUKAEMIA IN GREAT BRITAIN, 1980-2007<br />

Anjali Shah<br />

SEASONALITY OF DIAGNOSIS IN CANCER AMONGST 15-24 YEAR OLDS IN ENGLAND, 1996-2005<br />

Marlous van Laar<br />

A RECORD-BASED CASE-CONTROL STUDY OF NATURAL BACKGROUND RADIATION AND THE INCIDENCE OF<br />

CHILDHOOD CANCER IN GREAT BRITAIN<br />

Gerry Kendall<br />

CROSS-SPACE-TIME CLUSTERING OF CHILDHOOD CANCER IN GREAT BRITAIN: EVIDENCE FOR A COMMON<br />

AETIOLOGY<br />

Richard McNally<br />

TRENDS IN 5-YEAR SURVIVAL OF CHILDHOOD SOLID TUMOURS DIAGNOSED 1986-2010 IN THE NORDIC<br />

REGIONS (DENMARK, FINLAND, NORWAY, ICELAND AND SWEDEN)<br />

Milada Cvancarova Småstuen<br />

INCIDENCE OF SKELETAL-RELATED EVENTS AMONG CHILDREN WITH CANCER AND BONE METASTASES IN<br />

DENMARK<br />

Merete Lund Maegbaek<br />

OUTCOMES OF ONCOLOGY CLINICAL TRIAL ENROLMENT IN ADOLESCENT AND YOUNG ADULTS<br />

Sarah McKillop<br />

THE PRESENT SITUATION IN SPAIN OF ADOLESCENTS WITH CANCER IN PEDIATRIC HEMATOLOGY-<br />

ONCOLOGY UNITS. RESULTS OF A NATIONAL SURVEY<br />

Alvaro Lassaletta<br />

SURVEILLANCE AND SURVIVAL AMONG ADOLESCENTS AND YOUNG ADULTS WITH CANCER IN ONTARIO,<br />

CANADA<br />

Ronald Barr<br />

INSURANCE STATUS AND CANCER DISPARITIES IN ADOLESCENTS AND YOUNG ADULTS 15 TO 39 YEARS OF<br />

AGE, US NATIONAL CANCER DATA BASE, 1998−2003<br />

Ronald Barr<br />

CANCER INCIDENCE AND SURVIVAL AMONG CHILDREN AND ADOLESCENTS IN ISRAEL DURING THE YEARS<br />

1998-2007<br />

Myriam Weyl Ben-Arush<br />

PP004<br />

PP005<br />

PP007<br />

PP006<br />

PP008<br />

PP009<br />

PP010<br />

PP011<br />

PP012<br />

PP013<br />

PP014<br />

PP015<br />

PP016<br />

PP017<br />

PP018<br />

PP019

TRENDS IN INCIDENCE OF PRIMARY CUTANEOUS MALIGNANCIES IN CHILDREN, ADOLESCENTS AND YOUNG<br />

ADULTS: A POPULATION-BASED STUDY<br />

Andreza Senerchia<br />

RELATIVE SURVIVAL PROFILE OF PAEDIATRIC AND NON-PAEDIATRIC LOW GRADE GLIOMAS<br />

Nicolas Smoll<br />

CLINICAL CHARACTERISTICS AND OUTCOMES OF HIV-INFECTED CHILDREN DIAGNOSED WITH KAPOSI<br />

SARCOMA IN MALAWI AND BOTSWANA<br />

Parth Mehta<br />

SOCIO-ECONOMIC STATUS PLAYS IMPORTANT ROLE IN CHILDHOOD CANCER TREATMENT OUTCOME<br />

Saskia Mostert<br />

COMPARISON OF ANTICIPATED AND ACTUAL CONTROL GROUP OUTCOME IN RANDOMISED TRIALS IN<br />

PAEDIATRIC ONCOLOGY PROVIDES EVIDENCE THAT NON-RANDOMISED STUDIES ARE BIASED IN FAVOUR<br />

OF THE NOVEL TREATMENT<br />

Veronica Moroz<br />

INTRODUCING RELIABILITY INTO PRESCRIBING PRACTICE: REDUCING THE RISK AND IMPACT OF<br />

MEDICATION PRESCRIBING ERRORS ON HAEMATOLOGY / ONCOLOGY PATIENTS - THE GREAT ORMOND<br />

STREET EXPERIENCE<br />

Bhumik Patel<br />

CANCER IN CHILDREN WITH SYNDROMES: BAD LUCK AMPLIFIED IN THE DEVELOPING WORLD<br />

Vasant Ranganath Chinnabhandar<br />

FIVE YEARS OF ONCOPEDIA. AN INTERACTIVE EDUCATIONAL WEBSITE FOR PEDIATRIC ONCOLOGY<br />

Guillermo Luis Chantada<br />

PATTERN OF REFUSAL TO TREAT AND ABANDONMENT IN A NEW PEDIATRIC ONCOLOGY UNIT IN SOUTHERN<br />

INDIA<br />

Narendra Chaudhary<br />

<strong>SIOP</strong> PEDIATRIC ONCOLOGY IN DEVELOPING COUNTRIES (PODC) ABANDONMENT OF TREATMENT WORKING<br />

GROUP: AN EVALUATION OF PROGRESS<br />

Ca<strong>the</strong>rine G. Lam<br />

P-MEDICINE: A SOLUTION FOR TRANSLATIONAL RESEARCH?<br />

Norbert Graf<br />

RECENT MELANOMA INCIDENCE ACROSS ENGLAND AND AMONG WHITE RESIDENTS IN YOUNG PEOPLE<br />

RELATIVE TO ADULTS<br />

Sarah C. Wallingford<br />

Poster Topic: Late effects - Session 1<br />

Moderator: Jacqueline Loonen<br />

PQ001 - PQ021<br />

GENETIC RISK FACTORS OF ANTHRACYCLINE CARDIOTOXICITY - RELEVANT POLYMORPHISMS IDENTIFIED IN<br />

ENZYMES AND TRANSPORTERS OF ANTHRACYCLINE PHARMACOKINETICS<br />

Daniel Janos Erdelyi<br />

MYOCARDIAL 2D STRAIN ECHOCARDIOGRAPHY AND CARDIAC BIOMARKERS IN CHILDREN DURING AND SHORTLY<br />

AFTER ANTHRACYCLINE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL). A PROSPECTIVE STUDY<br />

Annelies Marie Mavinkurve-Groothuis<br />

PP020<br />

PP021<br />

PP022<br />

PP023<br />

PP024<br />

PP025<br />

PP026<br />

PP027<br />

PP028<br />

PP029<br />

PP030<br />

PP031<br />

Poster Board No<br />

PQ001<br />

PQ002<br />

Poster sessions

Poster sessions<br />

HYPOTHALAMIC-PITUITARY-ADRENAL AXIS FUNCTION IN SURVIVORS OF CHILDHOOD ACUTE<br />

LYMPHOBLASTIC LEUKEMIA<br />

Maartje Gordijn<br />

CAVERNOMAS AND BRAIN CYSTS AS TREATMENT-RELATED SEQUELAE IN SURVIVORS OF PEDIATRIC BRAIN<br />

TUMOURS<br />

Alessio Casutt<br />

DIABETES MELLITUS IN LONG TERME CHILDHOOD CANCER SURVIVORS: ROLE OF RADIATION DOSE TO THE<br />

TAIL OF THE PANCREAS<br />

Florent de Vathaire<br />

THE METABOLIC SYNDROME IN CHILDHOOD CANCER SURVIVORS, ADIPOCYTOKINES AND<br />

CARDIOVASCULAR EFFECTS<br />

Helene L. Hooimeijer<br />

SECOND MALIGNANCIES IN SURVIVORS OF A MALIGNANT BONE TUMOUR TWENTY FIVE YEARS POST<br />

TREATMENT<br />

Helene L. Hooimeijer<br />

LONG-TERM INTELLECTUAL DECLINE IN ADULT SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC<br />

LEUKEMIA TREATED WITH CRANIAL RADIATION<br />

Kevin R. Krull<br />

PULMONARY FUNCTION FOLLOWING ALLOGENEIC STEM CELL TRANSPLANT IN PEDIATRIC CANCER<br />

PATIENTS IN FINLAND: A RETROSPECTIVE COHORT STUDY OF 51 PATIENTS<br />

Laura-Maria Madanat-Harjuoja<br />

LATE CARDIAC DYSFUNCTION, ESPECIALLY DIASTOLIC, IS COMMON AFTER ANTHRACYCLINE USAGE AND<br />

MAY OCCUR EVEN AT LOWER “SAFE” DOSES<br />

Shailesh Anil Kanvinde<br />

LONG-TERM NEUROCOGNITIVE DEFICITS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA SURVIVORS:<br />

STUDYING THE POTENTIAL ROLE OF CELLULAR SENESCENCE<br />

Sophie Marcoux<br />

VASCULAR ENDOTHELIAL FUNCTION IN LONG-TERM SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC<br />

LEUKEMIA: EFFECTS OF A HOME-BASED EXERCISE PROGRAM<br />

Päivi Maria Lähteenmäki<br />

EPIDEMIOLOGY OF LATE ONSET ANTHRACYCLINE INDUCED MYOCARDIAL DYSFUNCTION IN CHILDHOOD<br />

CANCER SURVIVORS<br />

Sandeep Seth<br />

CHEST HEALTH SURVEILLANCE UTILITY IN EARLY DETECTION OF BRONCHIOLITIS OBLITERANS SYNDROME<br />

IN CHILDREN POST HAEMATOPOIETIC STEM CELL TRANSPLANTATION<br />

Adam Gassas<br />

GONADAL FUNCTION RECOVERY IN VERY LONG-TERM MALE SURVIVORS OF CHILDHOOD CANCER<br />

Wendy van Dorp<br />

GENETIC VARIATION MAY MODIFY OVARIAN RESERVE IN FEMALE CHILDHOOD CANCER SURVIVORS<br />

Wendy van Dorp<br />

CHILDHOOD CANCER SURVIVORS’ PERSPECTIVES AND PREFERENCES FOR LONG-TERM MEDICAL FOLLOW-UP<br />

Karen Jane Goddard<br />

PQ003<br />

PQ004<br />

PQ005<br />

PQ006<br />

PQ007<br />

PQ008<br />

PQ009<br />

PQ010<br />

PQ011<br />

PQ012<br />

PQ013<br />

PQ014<br />

PQ015<br />

PQ016<br />

PQ017

LONGITUDINAL CHANGES IN BODY MASS INDEX AND BODY COMPOSITION AMONG 417 ADULT SURVIVORS<br />

OF CHILDHOOD CANCER<br />

Karin Blijdorp<br />

GLOMERULAR FILTRATION RATES IN LONG-TERM SURVIVORS OF WILMS TUMOUR<br />

Jessica Bate<br />

NEUROCOGNITIVE FUNCTION IS REDUCED IN LONG-TERM SURVIVORS OF ACUTE LYMPHOBLASTIC<br />

LEUKEMIA TREATED WITH CHEMOTHERAPY ONLY - BUT POORER PERFORMANCE IS NOT ASSOCIATED WITH<br />

HIGHER TREATMENT BURDEN<br />

Adriani Kanellopoulos<br />

PHYSIOLOGIC FRAILTY IN ADULT SURVIVORS OF CHILDHOOD CANCER; A REPORT FROM THE ST. JUDE<br />

LIFETIME COHORT STUDY<br />

Kirsten K Ness<br />

Poster Topic: Late effects - Session 2<br />

Moderator: Adam Glaser<br />

PQ022 - PQ042<br />

HOSPITALISATION OF CHILDHOOD CANCER SURVIVORS: LINKAGE OF A COHORT TO A NATIONAL REGISTRY<br />

OF HOSPITALISATION DATA<br />

Elske Sieswerda<br />

RECORD LINKAGE OF A COHORT OF CHILDHOOD CANCER SURVIVORS WITH POPULATION REGISTRIES TO<br />

STUDY CLINICAL EVENTS<br />

Elske Sieswerda<br />

SURVIVOR HEALTHCARE PASSPORT: A TOOL TO EDUCATE AND ENHANCE THE CARE OF SURVIVORS OF<br />

CHILDHOOD CANCER<br />

Robert Goldsby<br />

LONG-TERM EFFECTS OF CRANIAL IRRADIATION AND INTRATHECAL CHEMOTHERAPY IN TREATMENT OF<br />

CHILDHOOD LEUKEMIA: A MEG STUDY OF POWER SPECTRUM AND CORRELATED COGNITIVE DYSFUNCTION<br />

Ilse Schuitema<br />

TASTE AND SMELL FUNCTION IN CHILDHOOD CANCER SURVIVORS AND THEIR AFFECTS ON QOL AND FOOD<br />

PREFERENCES<br />

Jennifer Cohen<br />

CHANGE IN IQ OVER TIME AMONG PEDIATRIC BRAIN TUMOUR PATIENTS TREATED WITH PROTON BEAM<br />

RADIATION THERAPY VERSUS CONVENTIONAL RADIATION THERAPY<br />

Lisa S. Kahalley<br />

LIFE CHALLENGES EXPERIENCED BY LONG-TERM PEDIATRIC BRAIN TUMOUR SURVIVORS: PARENTS´<br />

PERSPECTIVES<br />

Karen Jane Goddard<br />

FEASIBILITY OF POSTAL FOLLOW-UP FOR LOW RISK SURVIVORS OF CHILDHOOD CANCER<br />

Helen Jenkinson<br />

RISK STRATIFICATION: A MODEL FOR THE FUTURE<br />

Helen Jenkinson<br />

RISK OF CONGENITAL MALFORMATIONS IN CHILDREN OF CHILDHOOD CANCER SURVIVORS<br />

Anja Borgmann-Staudt<br />

PQ018<br />

PQ019<br />

PQ020<br />

PQ021<br />

Poster Board No<br />

PQ022<br />

PQ023<br />

PQ024<br />

PQ025<br />

PQ026<br />

PQ027<br />

PQ028<br />

PQ029<br />

PQ030<br />

PQ031<br />

Poster sessions

Poster sessions<br />

MORBIDITY AMONG SWEDISH SURVIVORS OF ACUTE LYMPHOBLASTIC LEUKAEMIA IN CHILDHOOD<br />

Anna Sällfors Holmqvist<br />

EVALUATION OF CISPLATINUM OTOTOXICITY AND ITS EFFECT ON QUALITY OF LIFE IN LONG-TERM SURVIVORS<br />

Mehmet Kantar<br />

SUICIDAL RISK AMONG CHILDHOOD CANCER SURVIVORS IN SLOVENIA<br />

Lorna Zadravec Zaletel<br />

EXPLORING CHILDHOOD CANCER SURVIVORS’ UNDERSTANDING OF THE EFFECTS OF THERAPY ON THEIR<br />

FERTILITY<br />

Kristina L Chapman<br />

FREQUENCY OF FEMORAL AND TIBIA FRACTURES REQUIRING HOSPITALISATION IN CHILDREN AND YOUNG<br />

ADULTS TREATED FOR LEUKAEMIA OR LYMPHOMA: A NATIONWIDE, REGISTER-BASED STUDY IN FINLAND<br />

AND DENMARK<br />

Riitta Niinimäki<br />

AN UPDATE FROM SINGAPORE CHILDHOOD CANCER SURVIVOR STUDY (SINGAPORE-CCSS)<br />

LeLe Aung<br />

OVERWEIGHT IN ACUTE LEUKEMIA SURVIVORS IS DUE TO IMBALANCE OF ENERGY INTAKE AND TOTAL<br />

ENERGY EXPENDITURE<br />

Richa Ravindra<br />

THYROID FUNCTION EVALUATION IN CHILDREN DIAGNOSED AND TREATED FOR CHILDHOOD ACUTE<br />

LYMPHOBLASTIC LEUKEMIA<br />

Vassilios Papadakis<br />

FERTILITY AND SPERM CRYOPERSERVATION IN YOUNG MALE ADOLESCENT PATIENTS FOLLOWING CANCER<br />

DIAGNOSIS<br />

Vassilios Papadakis<br />

NEUROPSYCHOLOGICAL FUNCTIONING OF CHILDREN TREATED WITH INTENSIVE CHEMOTHERAPY<br />

FOLLOWED BY MYELOABLATIVE CONSOLIDATION CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC<br />

CELL RESCUE FOR NEWLY DIAGNOSED CNS TUMOURS: LONG-TERM FOLLOW-UP ANALYSIS OF THE “HEAD<br />

START II” SURVIVORS<br />

Stephen Alan Sands<br />

N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE FOR PREDICTION OF CYCLOPHOSPHAMIDE-INDUCED<br />

CARDIOTOXICITY IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY<br />

Soo Hyun Lee<br />

Poster Topic: Supportive care/Palliative care<br />

Moderator: Lillian Sung<br />

PR001 - PR038<br />

FUNGAL INFECTIONS IN PAEDIATRIC ONCOLOGY PATIENTS, AN 11 YEAR STUDY<br />

Aisleen Bennett<br />

PREDICTORS OF ADVERSE OUTCOME IN CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA IN CHILDREN<br />

Maya Prasad<br />

EVALUATION OF SERUM GALACTOMANNAN ASSAY FOR THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS IN<br />

CHILDREN WITH HEMATOLOGICAL MALIGNANCIES<br />

Ajaya Kumar Jha<br />

PQ032<br />

PQ033<br />

PQ034<br />

PQ035<br />

PQ036<br />

PQ037<br />

PQ038<br />

PQ039<br />

PQ040<br />

PQ041<br />

PQ042<br />

Poster Board No<br />

PR001<br />

PR002<br />

PR003

DIFFERENT FEVER DEFINITIONS AND THE RATE OF FEVER IN NEUTROPENIA DIAGNOSED IN CHILDREN<br />

WITH CANCER. A RETROSPECTIVE TWO-CENTER COHORT STUDY<br />

Roland A. Ammann<br />

THE SEVERITY OF ANEMIA IS ASSOCIATED WITH THE RISK OF ADVERSE EVENTS IN CHILDREN WITH CANCER<br />

AND FEVER IN NEUTROPENIA<br />

Roland A. Ammann<br />

IS SCHOOL ATTENDANCE DURING INITIAL CHILDHOOD CANCER TREATMENT ASSOCIATED WITH INFECTION?<br />

Margareta Af Sandeberg<br />

RISK FACTORS FOR BACTEREMIA IN PEDIATRIC PATIENTS WITH CANCER AND NON-NEUTROPENIC FEVER<br />

Maria Luisa Sulis<br />

INFECTIOUS AND OTHER COMPLICATIONS OF CENTRAL VENOUS CATHETERS IN PAEDIATRIC ONCOLOGY<br />

PATIENTS: THE EXPERIENCE OF TWENTY-ONE THOUSAND LINE-DAYS IN A UK REGIONAL CENTRE IN 2010<br />

Elizabeth Calton<br />

VARICELLA ZOSTER IMMUNE STATUS IN CHILDREN TREATED FOR ACUTE LEUKAEMIA<br />

Soonie R Patel<br />

VACCINATION STATUS OF CHILDREN WITH CANCER AFTER COMPLETION OF STANDARD-DOSE<br />

CHEMOTHERAPY AND AFTER HAEMATOPOIETIC STEM CELL TRANSPLANT<br />

Soonie R Patel<br />

AN INITIAL ATTEMPT TO STRATIFY CHILDREN WITH CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA<br />

Cristina Mata Fernández<br />

HUMAN SERUM-DERIVED IMMUNOGLOBULINS REDUCE BACTERIAL VIRULENCE IN AN IN VITRO MODEL FOR<br />

ORAL MUCOSITIS<br />

Sonja Lüer<br />

CURCUMIN AGAINST CANCER THERAPY INDUCED MUCOSITIS: COMPARISON OF PURE SYNTHETIC VERSUS<br />

NATURAL PURIFIED CURCUMIN IN AN IN VITRO MUCOSITIS MODEL<br />

Sonja Lüer<br />

HOME TO HOSPITAL INTERVAL IN CHILDREN WITH FEBRILE NEUTROPENIA IN ALL<br />

Sapna Oberoi<br />

VARIATIONS IN COMPLETE BLOOD CELL COUNTS AND SPECIFIC INFLAMMATORY PARAMETERS AS<br />

PREDICTORS FOR INVASIVE INFECTION IN PEDIATRIC ONCOLOGY PATIENTS WITH FEVER AND NEUTROPENIA<br />

Joseph Kapelushnik<br />

CLINICO-LABORATORY PROFILE OF HEPATITIS C VIRUS INFECTION AND EFFECT OF RIBAVIRIN<br />

MONOTHERAPY IN CHILDREN ON CANCER CHEMOTHERAPY - A PILOT STUDY<br />

Archana Kumar<br />

THE UTILITY OF CYSTATIN C FOR EVALUATION OF RENAL FUNCTION IN PEDIATRIC CANCER PATIENTS<br />

Yoshiki Katsumi<br />

RAPID HYDRATION: SMALL CHANGE WITH BIG GAINS<br />

Kathleen Magee<br />

USE OF TRADITIONAL COMPLEMENTARY/ALTERNATIVE MEDICINE (TCAM) AMONG CHILDREN WITH CANCER<br />

IN BUENOS AIRES, ARGENTINA<br />

Guillermo Chantada<br />

PR004<br />

PR005<br />

PR006<br />

PR007<br />

PR008<br />

PR009<br />

PR010<br />

PR011<br />

PR012<br />

PR013<br />

PR014<br />

PR015<br />

PR016<br />

PR017<br />

PR018<br />

PR019<br />

Poster sessions

Poster sessions<br />

PHYSICAL ACTIVITY (PA) AND SLEEP AMONG CHILDREN AND ADOLESCENTS WITH CANCER<br />

Andrea D. Orsey<br />

RISK-BASED THERAPY FOR FEBRILE PATIENTS WITH NEUTROPENIA: A ROLE FOR EARLY HOSPITAL<br />

DISCHARGE<br />

Cristina Mata Fernández<br />

SHOULD THERE BE GUIDELINES ON HORMONAL THERAPY IN THE PREVENTION OF MENSTRUATION IN<br />

TEENAGE GIRLS RECEIVING CHEMOTHERAPY FOR CANCER?<br />

Boo Messahel<br />

BETTER OUTCOME OF COMBINED GASTROINTESTINAL AND SKIN GVHD COMPARED TO ISOLATED<br />

GASTROINTESTINAL GVHD IN CHILDREN POST ALLOGENEIC STEM CELL TRANSPLANTATION (SCT)<br />

Adam Gassas<br />

ANTIBIOTIC AND OTHER LOCK TREATMENTS FOR TUNNELLED CENTRAL VENOUS CATHETER RELATED<br />

INFECTIONS IN CHILDREN WITH CANCER: A SYSTEMATIC COCHRANE REVIEW<br />

Reineke Anna Schoot<br />

SYSTEMIC TREATMENTS FOR THE PREVENTION OF VENOUS THROMBO-EMBOLIC EVENTS IN PAEDIATRIC<br />

CANCER PATIENTS WITH TUNNELLED CENTRAL VENOUS CATHETERS: A SYSTEMATIC COCHRANE REVIEW<br />

Reineke Anna Schoot<br />

NITROUS OXIDE IS AS EFFECTIVE AS KETAMINE-MIDAZOLAM SEDATION FOR PROCEDURE RELATED PAIN IN<br />

CHILDREN WITH CANCER<br />

Satya Prakash Yadav<br />

THE EFFECTS OF EXERCISE TRAINING ON CARDIORESPIRATORY FITNESS AND MUSCLE STRENGTH IN<br />

CHILDREN WITH HEMATOLOGICAL MALIGNANCIES: OBSERVATIONS IN CLINICAL PRACTICE<br />

Patrick Van Der Torre<br />

CAN WE OMIT PLAIN CT SCAN WHILE PERFORMING AN ABDOMINAL SCAN AND THUS REDUCE THE<br />

RADIATION BURDEN IN CHILDREN? IMAGE GENTLY A RATIONAL APPROACH<br />

Seema Ashish Kembhavi<br />

CHEMOTHERAPY PASSPORT: A TOOL TO IMPROVE SAFE DELIVERY OF CHEMOTHERAPY<br />

Uma Athale<br />

PREVALENCE OF VITAMIN C DEFICIENCY IN PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL<br />

TRANSPLANTATION<br />

Sunil Bhat<br />

PARENT FEEDING INTERACTIONS AND PRACTICES DURING CHILDHOOD CANCER TREATMENT: A<br />

QUALITATIVE INVESTIGATION<br />

Catharine Fleming<br />

NUTRITION OF CHILDREN RECEIVING HEMATOPOIETIC CELL TRANSPLANTATION<br />

Terezie Tolar Mosby<br />

PSYCHOLOGICAL HEALTH IN SIBLINGS WHO LOST A BROTHER OR SISTER TO CANCER TWO TO NINE YEARS<br />

EARLIER<br />

Alexandra Eilegard<br />

THE IMPACT OF COMMUNICATION PRIOR TO AND FOLLOWING THE LOSS OF A BROTHER OR SISTER TO<br />

CANCER - A NATIONWIDE LONG-TERM FOLLOW-UP<br />

Alexandra Eilegard<br />

PR020<br />

PR021<br />

PR022<br />

PR023<br />

PR024<br />

PR025<br />

PR026<br />

PR027<br />

PR028<br />

PR029<br />

PR030<br />

PR031<br />

PR032<br />

PR033<br />

PR034

IDENTIFYING THE HEALTH AND SUPPORTIVE CARE NEEDS OF ADOLESCENT AND YOUNG ADULT CANCER<br />

PATIENTS AND SURVIVORS<br />

Elena Tsangaris<br />

CREATING A CHILD SELF-REPORT MEASURE OF ADVERSE EVENTS RELATED TO CANCER TREATMENT<br />

Pamela S. Hinds<br />

PAEDIATRIC ONCOLOGY REFERENCE TEAM (PORT) WORKS TO ENSURE THAT THE INFORMATION GIVEN TO<br />

PARENTS, CHILDREN AND YOUNG PEOPLE IN THE UK IS ACCESSIBLE, IN EASY TO UNDERSTAND LANGUAGE<br />

AND EXPLAINED WELL AND APPROPRIATE FOR EACH AGE GROUP<br />

Neil Ranasinghe<br />

TRANSITION OR TRANSFER? AN EXPERIENTIAL PERSPECTIVE ON MOVING FROM PAEDIATRIC TO ADULT<br />

CANCER SERVICES<br />

Lisa McCann<br />

Poster Topic: Psychosocial<br />

Moderator: Maria McCarthy<br />

PS001 - PS034<br />

IMPORTANT FACTORS TO UNDERSTANDING QUALITY OF LIFE ACCORDING TO CHILDREN WITH CANCER AND<br />

CHILDHOOD CANCER SURVIVORS<br />

Samantha J. Anthony<br />

EXPLORING RESPONSE SHIFT IN CHILDHOOD CANCER PATIENTS AND ITS EFFECT ON HRQL<br />

Aeltsje Brinksma<br />

HOSPITAL-BASED HOME CARE FOR CHILDREN WITH CANCER - HEALTHRELATED QUALITY OF LIFE AND THE<br />

PSYCHOSOCIAL IMPACT ON THE FAMILY<br />

Helena Hansson<br />

A NEW QUESTIONNAIRE TO MEASURE TEEN-CENTRED CARE IN PEDIATRIC ONCOLOGY: GIVE YOUTH A<br />

VOICE<br />

Anne Klassen<br />

DO ADOLESCENTS WITH CANCER AND HEALTHY PEERS DIFFER WITH REGARD TO THE CONTENT AND<br />

ABSTRACTION LEVEL OF THEIR SELF-GENERATED PERSONAL GOALS?<br />

Es<strong>the</strong>r Sulkers<br />

SELF PERCEPTION AND QUALITY OF LIFE IN ADOLESCENTS DURING TREATMENT FOR A MALIGNANT BONE<br />

TUMOUR<br />

Christel van Riel<br />

ONLINE GROUP-BASED COGNITIVE-BEHAVIOURAL THERAPY FOR ADOLESCENTS AND YOUNG ADULTS<br />

AFTER CANCER TREATMENT: THE RECAPTURE LIFE-AYA PILOT STUDY<br />

Ursula Sansom-Daly<br />

“I CAN DISCUSS THINGS I DON´T USUALLY TALK ABOUT”: EXPERIENCES OF A TIME ALONE MODEL FOR<br />

ADOLESCENT ONCOLOGY PATIENTS AND THEIR PARENTS IN THE PSYCHOSOCIAL REVIEW COMPONENT OF A<br />

LONG-TERM FOLLOW-UP CLINIC<br />

Maria C McCarthy<br />

RISKY SEXUAL BEHAVIOR IN ADOLESCENT SURVIVORS OF CHILDHOOD CANCER: A REPORT FROM THE<br />

CHILDHOOD CANCER SURVIVOR STUDY<br />

James L. Klosky<br />

PR035<br />

PR036<br />

PR037<br />

PR038<br />

Poster Board No<br />

PS001<br />

PS002<br />

PS003<br />

PS004<br />

PS005<br />

PS006<br />

PS007<br />

PS008<br />

PS009<br />

Poster sessions

Poster sessions<br />

YOUNG ADULT CANCER SURVIVOR’S EXPERIENCES OF PSYCHOSOCIAL REHABILITATION<br />

Jennie Stigmar<br />

THE IMPACT OF CANCER DIAGNOSIS ON PSYCHOSOCIAL HEALTH IN CHILDHOOD CANCER SURVIVORS -<br />

SINGLE INSTITUTION LONGITUDINAL STUDY QOLOP<br />

Tomas Kepak<br />

EMOTIONAL DISTRESS IN 652 DUTCH VERY LONG-TERM SURVIVORS OF CHILDHOOD CANCER, USING THE<br />

HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS)<br />

Ivana M.M. van der Geest<br />

SOMATIC COMPLAINTS IN SURVIVORS OF PEDIATRIC CANCER: THE ROLE OF EMOTION REGULATION<br />

Lynn Fainsilber Katz<br />

VERY LATE ONSET AND RECURRENT SUICIDE IDEATION IN ADULT SURVIVORS OF CHILDHOOD CANCER: A<br />

REPORT FROM THE CHILDHOOD CANCER SURVIVOR STUDY<br />

Tara M. Brinkman<br />

FAMILY ADAPTATION TO CHILDHOOD CANCER AND THE NEED FOR PSYCHOSOCIAL INTERVENTION<br />

Yiouli Ktena<br />

FAITH AND PROTECTION: THE CONSTRUCTION OF HOPE BY PARENTS OF CHILDREN WITH LEUKEMIA AND<br />

THEIR ONCOLOGISTS<br />

Tim Eden<br />

MASTERY AND OPTIMISM AS PREDICTORS OF DISTRESS IN PARENTS OF CHILDREN WITH CANCER<br />

Es<strong>the</strong>r Sulkers<br />

AVOIDANCE AND HYPERAROUSAL MEDIATE THE RELATIONSHIP BETWEEN REEXPERIENCING AND<br />

DYSPHORIA IN PARENTS OF CHILDREN WITH CANCER: A LONGITUDINAL ANALYSIS<br />

Martin Cernvall<br />

PARENTING A CHILD WITH CANCER: PARENT AND ADOLESCENT SURVIVORS’ PERCEPTIONS OF PARENTING<br />

STRATEGIES UTILISED DURING TREATMENT AND INTO SURVIVORSHIP<br />

Lauren Williams<br />

PREDICTORS OF PSYCHOPATHOLOGY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA UNDERGOING<br />

CHEMOTHERAPY<br />

Vineeta Gupta<br />

COURSE OF EMOTIONAL ADJUSTMENT OF CHILDREN DIAGNOSED WITH ACUTE LYMPHOBLASTIC<br />

LEUKAEMIA: FROM DIAGNOSIS UNTIL END OF TREATMENT<br />

Simone M. Sint Nicolaas<br />

ACUTE NEUROPSYCHIATRIC EPISODES OF CORTICOSTEROIDS DURING INTENSIVE TREATMENT FOR ALL IN<br />

ADOLESCENT PATIENTS<br />

Marzena Samardakiewicz<br />

“HIT AND MISS”: PARENTS AND TEACHERS PERCEPTIONS OF EDUCATIONAL NEEDS FOLLOWING<br />

TREATMENT FOR A BRAIN TUMOUR<br />

Ellen Gentle<br />

SOCIAL AND EDUCATIONAL ISSUES FACING CHILDREN, WHO ARE IN REMISSION FROM BRAIN AND SPINAL<br />

TUMOURS, AS THEY REINTEGRATE INTO JAPAN’S MAINSTREAM ACADEMIC ENVIRONMENT<br />

Yoshiko Mimaki<br />

PS010<br />

PS011<br />

PS012<br />

PS013<br />

PS014<br />

PS015<br />

PS016<br />

PS017<br />

PS018<br />

PS019<br />

PS020<br />

PS021<br />

PS022<br />

PS023<br />

PS024

DETERMINANTS OF TREATMENT ABANDONMENT: PRELIMINARY RESULTS FROM A GLOBAL SURVEY BY THE<br />

<strong>SIOP</strong> PODC WORKING GROUP ON TREATMENT ABANDONMENT<br />

Paola Friedrich<br />

STRATEGIES CURRENTLY IN PLACE TO ADDRESS TREATMENT ABANDONMENT: PRELIMINARY RESULTS<br />

FROM A GLOBAL SURVEY BY THE <strong>SIOP</strong> PODC WORKING GROUP ON TREATMENT ABANDONMENT<br />

Paola Friedrich<br />

HELPING THE HELPERS: A PILOT STUDY OF MINDFULNESS TRAINING TO DECREASE BURNOUT AMONG<br />

PEDIATRIC ONCOLOGY STAFF MEMBERS<br />

Jerry Stein<br />

PSYCHOSOCIAL RISK IN FAMILIES CARING FOR A CHILD WITH CANCER: USE AND VALIDATION OF THE<br />

PSYCHOSOCIAL ASSESSMENT TOOL (PAT2.0) IN AN ITALIAN MULTICENTER SAMPLE<br />

Joan MC Blom<br />

THE VALUE OF INFORMATION IN GAINING TRUST- EXPERIENCES FROM CHILDREN´S CANCER HOSPITAL IN<br />

EGYPT<br />

Hanan El Malla<br />

REVIEW OF INTERVENTIONS FOR PROMOTING PARTICIPATION IN SHARED DECISION-MAKING FOR<br />

CHILDREN WITH CANCER<br />

Imelda Coyne<br />

PREVALENCE OF GRANDPARENTAL DISTRESS, SUPPORT SERVICE USAGE AND BARRIERS TO ACCESS: A<br />

COMPARISON OF GRANDPARENTS OF CHILDREN WITH CANCER AND MATCHED CONTROLS<br />

Claire E Wakefield<br />

THE LONG-TERM CONSEQUENCES OF UNRESOLVED GRIEF IN YOUNG ADULT SIBLINGS WHO HAVE LOST A<br />

BROTHER OR SISTER TO CANCER<br />

Josefin Sveen<br />

PEDIATRIC PATIENTS’ WITH CANCER AND PARENTS´ OPINIONS ABOUT THE PAIN THEY SUFFERED DURING<br />

THE HOSPITALISATION AND THE IMPACT OF PAIN UPON PARENTS´ QUALITY OF LIFE<br />

Vasiliki Matziou<br />

PATIENT REPORTED OUTCOMES (PROS) IN PAEDIATRIC ONCOLOGY PRACTICE: PERCEIVED FEASIBILITY BY<br />

ONCOLOGISTS AND PARENTS<br />

S.A. Schepers<br />

Poster Topic: Nursing<br />

Moderators : Tina Baggott, Margaretha Jenholdt Nolbris<br />

PU001 - PU017<br />

A DELINEATED UNIT ANALYSIS OF OUT OF POCKET EXPENSES INCURRED BY FAMILIES OF CHILDREN WITH<br />

CANCER<br />

Argerie Tsimicalis<br />

DECISION MAKING IN PEDIATRIC SURGICAL PATIENTS: CHALLENGES OF INFORMED CONSENT AND ASSENT<br />

WITH AN OLDER ADOLESCENT<br />

Sara O. Swaim<br />

IMPACT OF CANCER ON TEENAGERS AND CHALLENGES ON NURSES<br />

Gladys Mngomezulu<br />

PS025<br />

PS026<br />

PS027<br />

PS028<br />

PS029<br />

PS030<br />

PS031<br />

PS032<br />

PS033<br />

PS034<br />

Poster Board No<br />

PU001<br />

PU002<br />

PU003<br />

Poster sessions

Poster sessions<br />

SCHOOL FOR PARENTS: EXPERIENCE FROM A PEDIATRIC ONCOLOGY UNIT<br />

Cristina Llanos Príncipe<br />

MEASURING QUALITY IN CHILDREN AND YOUNG PEOPLES CANCER CARE: FOUNDATION ONCOLOGY SKILLS<br />

PROGRAMME DEVELOPMENT<br />

Emily Baker<br />

CHILDREN’S CANCER NURSES’ EXPERIENCES OF PROVIDING PALLIATIVE CARE IN THE ACUTE HOSPITAL<br />

SETTING<br />

Helen Pearson<br />

LIVING AN EVERYDAY LIFE SHADED WITH TRACES FROM THE CANCER TRAJECTORY - FAMILIES’ LIVED<br />

EXPERIENCES IN A SIX YEAR FOLLOW UP<br />

Maria Björk<br />

SENSE OF COHERENCE OVER TIME FOR PARENTS WITH A CHILD DIAGNOSED WITH CANCER<br />

Maria Björk<br />

ENTERAL FEEDING-DOES IT HAVE APLACE IN ADVANCED CANCER?<br />

Maggie Breen<br />

INDEPENDENT NON MEDICAL PRESCRIBING PRACTICE WITHIN A MULTIDISCIPLINARY TEAM OF ONE UK<br />

TERTIARY CHILDREN’S CANCER CENTRE<br />

Maggie. Breen<br />

CLIC SARGENT PAEDIATRIC ONCOLOGY SPECIALIST NURSE KEY WORKER PROJECT<br />

Simon Morgan-Jones<br />

HOSPITAL-BASED HOME CARE FOR CHILDREN WITH CANCER - A QUALITATIVE EXPLORATION OF FAMILY<br />

MEMBERS’ EXPERIENCES IN DENMARK<br />

Helena Hansson<br />

ADOLESCENTS’ AND YOUNG ADULTS’ VIEWS OF DAILY LIFE FIVE YEARS AFTER A CHILDHOOD CANCER<br />

DIAGNOSIS<br />

Eva Berg Doukkali<br />

IMPORTANT NEEDS IN CARE SITUATIONS FOR TEENAGERS AND YOUNG ADULT CANCER PATIENTS<br />

Maria Olsson<br />

REWARDS AND CHALLENGES OF NURSES WORKING IN A DEVELOPING COUNTRY: WHAT DOES IT TAKE?<br />

Linda Abramovitz<br />

A SURVEY OF STRESS RESOURCES AMONG PARENTS OF CRITICALLY ILL CHILDREN IN PEDIATRIC ONCOLOGY WARD<br />

Mitra Soltanian<br />

NURSES AS STAKEHOLDERS AND PARTICIPANTS IN THE DEVELOPMENT OF A DATA MANAGEMENT SYSTEM<br />

FOR HEMATOLOGY/ONCOLOGY: LESSONS FROM A TERTIARY CARE INSTITUTION IN ETHIOPIA<br />

Ge<strong>of</strong>frey Colin Buckle<br />

PU004<br />

PU005<br />

PU006<br />

PU007<br />

PU008<br />

PU009<br />

PU010<br />

PU011<br />

PU012<br />

PU013<br />

PU014<br />

PU015<br />

PU016<br />

PU017

Poster Topic: Surgery (IPSO)<br />

Moderator: Sushmita Bhatnagar<br />

PW001 - PW016<br />

POSTOPERATIVE INTUSSUSCEPTION IN PEDIATRIC ABDOMINAL MALIGNANCIES: A RARE FORGOTTEN CAUSE<br />

OF EARLY POSTOPERATIVE INTESTINAL OBSTRUCTION<br />

Gehad Taha Meselhy<br />

PRIMARY INTESTINAL LYMPHOMA IN CHILDREN: ROLE OF SURGERY & STUDY OF SURVIVAL<br />

Yasser Sadek<br />

DIDACTIC INTERACTIVE MULTIMEDIA “PEDIATRIC SURGICAL ONCOLOGY”<br />

Andrés José Pi Osoria<br />

ADRENAL TUMOURS IN CHILDREN<br />

Dae Yeon Kim<br />

CATHETER-RELATED INFECTIONS AND CATHETER THROMBOSIS IN CHILDREN WITH CANCER<br />

Maxim Rykov<br />

PAPILLARY AND FOLLICULAR THYROID CARCINOMA IN CHILDREN: TREATMENT AND RESULTS<br />

Ruslan Vladimirovich Shishkov<br />

TREATMENT STRATEGY OF VAGINAL ENDODERMAL SINUS TUMOUR - EXPERIENCE OF A SINGLE CENTER<br />

Huanmin Wang<br />

JUVENILE GRANULOSA CELL TUMOUR OF THE OVARY<br />

Rajan Garg<br />

INTERNAL HEMIPELVECTOMY AS A TREATMENT OPTION IN BONE TUMOURS IN CHILDREN AND YOUTH<br />

Wojciech Wozniak<br />

PROBLEMS AMONG CHILDHOOD CANCER SURVIVORS IN A PEDIATRIC SURGICAL CLINIC<br />

Takaharu Oue<br />

LONG TERM IMPLANTABLE CATHETERS IN CHILDREN: EXPERIENCE OF THE PEDIATRIC ONCOLOGY INSITUTE<br />

OF THE FEDERAL UNIVERSITY OF SÃO PAULO IN TWO PERIODS<br />

Simone De Campos Vieira Abib<br />

BILATERAL WILMS TUMOUR: EXPERIENCE OF THE PEDIATRIC ONCOLOGY INSITUTE OF THE FEDERAL<br />

UNIVERSITY OF SÃO PAULO<br />

Simone De Campos Vieira Abib<br />

PRIMARY CERVICAL NEUROBLASTOMA: SINGLE INSTITUTION EXPERIENCE<br />

Deepti Mishra<br />

POSSIBILITY OF PARTIAL NEPHRECTOMY IN CHILDREN WITH WILMS TUMOUR - ANALYSIS OF PATHOLOGICAL<br />

POSTOPERATIVE SPECIMENS OF 12 CASES<br />

Krzyszt<strong>of</strong> Bronowicki<br />

CLINICAL FEATURES AND SURGICAL INTERVENTION OF RENAL TUMOURS DIAGNOSED DURING EARLY<br />

INFANCY<br />

Shigehisa Fumino<br />

ASKIN TUMOUR OF THE CHEST WALL - OUTCOME AFTER COMBINED TREATMENT WITH CHEMOTHERAPY,<br />

SURGERY AND RADIOTHERAPY IN A SINGLE CENTRE<br />

Anna Krickhahn<br />

Poster Board No<br />

PW001<br />

PW002<br />

PW003<br />

PW004<br />

PW005<br />

PW006<br />

PW007<br />

PW008<br />

PW009<br />

PW010<br />

PW011<br />

PW012<br />

PW013<br />

PW014<br />

PW015<br />

PW016<br />

Poster sessions

Poster sessions<br />

Poster Topic: Radiation Oncology (PROS)<br />

Moderators: Christian Carrie, Carolyn Freeman<br />

PX001 - PX010<br />

ROLE OF PALLIATIVE RADIOTHERAPY IN THE MANAGEMENT OF ADVANCE PEDIATRIC CANCERS<br />

Tanweer Shahid<br />

COMPARISON OF VOLUMETRIC MODULATED ARC THERAPY (VMAT) VS. CONVENTIONAL RADIOTHERAPY<br />

WITH INTENSITY MODULATED RADIATION THERAPY (IMRT) BOOST IN CRANIOSPINAL IRRADIATION (CSI) OF<br />

PEDIATRIC MEDULLOBLASTOMA<br />

Anirudh Urumi Punnakal<br />

IMPACT OF RADIATION THECNIQUES 3D VS IMRT ON ACUTE TOXICITY AND LOCAL CONTROL IN PATIENTS<br />

WITH RHABDOMYOSARCOMA<br />

Ana Mabel Martinez<br />

AGE RELATED CHANGES IN FRONTAL LOBE ANATOMY REQUIRE PATIENT SPECIFIC CRANIOSPINAL<br />

IRRADIATION TREATMENT MARGINS<br />

Jeffrey Craig Buchsbaum<br />

PATTERN OF RELAPSE AFTER RADIOTHERAPY IN CHILDREN WITH CEREBRAL ATYPICAL TERATOID AND<br />

RHABDOID TUMOURS<br />

Violaine Beneyton<br />

HIPPOCAMPAL SPARING CRANIOSPINAL IRRADIATION IN MEDULLOBLASTOMA PATIENTS: A DOSIMETRIC<br />

STUDY USING INTENSITY-MODULATED RADIOTHERAPY<br />

Sheena Jain<br />

CONFORMAL PEDIATRIC RADIOTHERAPY IN SERBIA<br />

Jelena Bokun<br />

DIFFUSE PONTINE GLIOMAS OF THE CHILDHOOD: DOES TEMOZOLOMIDE IMPROVE SURVIVAL?<br />

Yavuz Anacak<br />

IMPACT OF MOTION IN ADVANCED PAEDIATRIC ABDOMINAL RADIOTHERAPY<br />

Syed Moinuddin<br />

MYXOPAPILLARY EPENDYMOMAS OF THE FILUM TERMINALE IN CHILDREN TREATED WITH SURGERY AND<br />

RADIATION<br />

Ricardo Wang<br />

Poster Board No<br />

PX001<br />

PX002<br />

PX003<br />

PX004<br />

PX005<br />

PX006<br />

PX007<br />

PX008<br />

PX009<br />

PX010

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!